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Phosphoenolpyruvate carboxykinase (PCK, GTP; EC4.1.1.32) catalyzes the 
conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), a critical reaction for 
gluconeogenesis.  The two isoforms of PCK, namely cytosolic PCK (PCK1), and the 
mitochondrial PCK (PCK2) are abundantly expressed in liver and kidney.  Increased 
PCK1 activity and mRNA expression in liver is observed as feed intake recovers during 
early lactation in dairy cows, a condition linked to increased ruminal propionate 
production.  The central hypothesis of this dissertation is that propionate regulates its own 
metabolism in liver of dairy cattle through regulation of the PCK1 gene.  The objectives 
of this dissertation were to determine: 1) the effect of elevated propionate supply on 
expression of key genes for gluconeogenesis, particularly PCK1, in liver of dairy cattle; 
2) the effect of propionate on expression of PCK1 mRNA under controlled hormonal 
status in cultured primary bovine hepatocytes; 3) the effect of propionate on the 





cis-elements within the bovine PCK1 promoter responsible for the induction of PCK1 
expression by propionate.  
Postruminal infusion of propionate to mid-lactation cows and intravenous 
infusion of propionate to neonatal calves allowed evaluation of the effects of increased 
propionate supply on hepatic expression of the gluconeogenic genes.  These data 
indicated that mRNA expression of PCK1 and G6PC were at least maintained by 
propionate infusion in mid-lactation cows despite the greatly elevated blood insulin levels 
that suppressed the expression of these two genes without propionate infusion.  When 
blood insulin levels were not elevated, as observed in the neonatal calves, the mRNA 
expression of PCK1 and G6PC was increased. 
In vitro culture of bovine hepatocytes allowed examination of the direct effect of 
propionate on expression of PCK1 mRNA independent of hormonal status.  In this study, 
bovine hepatocytes were isolated from neonatal calves and cultured with propionate, 
insulin, cAMP, dexamethasone or their combinations.  These data demonstrated a direct 
role of propionate to induce PCK1 mRNA expression in the bovine hepatocytes.  
Propionate-induced PCK1 mRNA expression was mimicked by cAMP, but not by 
dexamethasone, and these effects were inhibited by addition of insulin.   
To investigate whether propionate regulates the PCK1 expression at 
transcriptional level, the promoter of the bovine PCK1 gene was cloned and ligated to 
Firefly luciferase reporter and transiently transfected into the rat hepatoma H4IIE cells.  
The effects of acetate, propionate, butyrate, glycerol, cAMP, dexamethasone and insulin 
on the activity of PCK1 promoter were determined.  These data indicated that the 





activation.  The induction of bovine PCK1 promoter by propionate or butyrate was not a 
general effect of short-chain fatty acids (SCFA) as acetate was without effect.  
Additionally, bovine PCK1 promoter was stimulated by cAMP and dexamethasone, 
however, to a much less extent compared with propionate.  Propionate, cAMP, and 
dexamethasone act synergistically to induce PCK1 transcription.  Addition of insulin 
repressed the promoter activation stimulated by cAMP and dexamethasone, but failed to 
inhibit the propionate-induced promoter activation.   
Furthermore, the underlying molecular mechanism and cis-regulatory elements 
within the bovine PCK1 promoter that is responsible for the responses to propionate, 
butyrate, cAMP and dexamethasone, as well as the synergistic effect of propionate, 
cAMP, and dexamethasone were investigated.  Particularly, the role of cAMP response 
element (CRE) and the binding sites for Hepatic Nuclear Factor 4α (HNF4α) were 
determined by site-direct mutagenesis.  These data suggested that propionate, butyrate, 
cAMP and dexamethasone shared common signaling pathway to mediate bovine PCK1 
transcription, and the consensus sequences for CRE located at -94 through -87 bp and 
HNF4α site located at +68 through +72 bp relative to the transcription start site of the 
bovine PCK1 gene were responsible for the maximum promoter induction of PCK1 
promoter as double deletions of these two sites completely abolished the responses to 
propionate, butyrate, cAMP, dexamethasone as well as the synergistic induction by 
propionate, cAMP and dexamethasone.  
Together, these data suggest a feed-forward mechanism that links propionate, a 
primary SCFA produced in the rumen, with its own metabolic fate through regulation the 





CHAPTER 1. LITERATURE REVIEW 
Introduction 
The tricarboxylic acid (TCA) cycle has been described as “a traffic cycle on a 
busy highway” (Owen et al., 2002), and anaplerosis and cataplerosis work together to 
ensure a balanced inflow and outflow of the intermediates during energy metabolism and 
biosynthetic processes. Anaplerosis and cataplerosis are terms used in biochemistry to 
describe reactions that replenish (anaplerosis) and drain (cataplerosis) the pools of 
metabolic intermediates in the TCA cycle. Pyruvate carboxylase (PC) is a major 
anaplerotic enzyme that refills the oxaloacetate (OAA) pool from pyruvate. 
Phosphoenolpyruvate carboxykinase (PCK; GTP; EC4.1.1.32) is a major cataplerotic 
enzyme that depletes the oxaloacetate (OAA) pool from TCA cycle. This is critical 
because even though the TCA cycle plays a central role in energy metabolism through 
acetyl CoA oxidation, the 4- or 5-carbon intermediates in the TCA cycle generated from 
catabolism of amino acids and propionate cannot be fully oxidized by the TCA cycle, and 
must be removed from the cycle via cataplerosis (Owen et al., 2002). In addition, 
cataplerosis may also provide intermediates for important biosynthetic processes such as 





acids.  Generation of phosphoenolpyruvate (PEP) from oxaloacetate (OAA) via PCK is a 
common pathway for supply intermediates for gluconeogenesis. 
During several physiological states, such as feeding, there are large influxes of 
intermediates catalyzed from amino acids or propionate in ruminant into the TCA cycle. 
Increased cataplerosis is required to remove the intermediates because the TCA cycle 
cannot be used as a carbon sink (Owen et al., 2002). The changes in anaplerotic and 
cataplerotic reactions may be exerted through changes in the corresponding enzymes. In 
turn, the status of anaplerosis and cataplerosis and the associated enzymes may regulate 
glucose, fatty acid, and amino acid metabolism. It has been observed for many years that 
increased glucose production is coupled with increased supply of propionate, which may 
not merely be a simple function of increased substrate concentration. However, the 
underlying biochemical and molecular mechanism have not been fully elucidated. This 
review will focus on the function and regulation of PCK as a cataplerotic enzyme, its role 
in several metabolic pathways associated with cataplerosis, and highlight unique 






Phosphoenolpyruvate carboxykinase  
Properties of the Enzyme   
Function Overview. Since its discovery in the 1950s, PCK has been recognized as 
a key enzyme for gluconeogenesis in liver and kidney.  It is noteworthy that PCK is 
expressed in tissues other than liver and kidney, such as white and brown adipose tissue, 
small intestine and mammary gland during lactation and therefore has functions in 
addition to gluconeogenesis in liver and kidney (Hanson and Garber, 1972, Zimmer and 
Magnuson, 1990).  Gluconeogenesis from glutamine via PCK in the kidney cortex is 
important for maintaining acid-base balance (Iynedjian et al., 1975, Parry and Brosnan, 
1980). The expression of PCK in adipose tissue and liver is related to de novo synthesis 
of glycerol, namely glyceroneogenesis, and supplies glycerol for re-esterification of free 
fatty acids to synthesize triglyceride; this process is active even during periods of net 
lipolysis (Hanson and Reshef, 2003, Reshef et al., 2003). The metabolic role of PCK has 
also been recently revealed to be related to gluconeogenesis in small intestine (Croset et 
al., 2001, Mithieux et al., 2004, De Vadder et al., 2014) and triglyceride synthesis in the 
mammary gland during lactation (Hsieh et al., 2008).  
Catalyzed Reaction. In vertebrates, PCK catalyzes the reversible reaction from 
OAA to PEP using GTP as a phosphoryl donor in a divalent cation-dependent reaction.  
This reaction is generally considered to be the first committed step in gluconeogenesis. 




 is required for the basal catalysis, and 





coupled with the carboxylation of pyruvate to OAA by PC, the thermodynamically 
unfavorable step in glycolysis catalyzed by pyruvate kinase to convert PEP and ADP to 
pyruvate and ATP can be reversed. The process of catalysis is carried out in a stepwise 
fashion, including binding of OAA to the divalent metal cation of PCK, binding of GTP 
to the nucleotide-binding site of PCK to form the PCK·OAA·GTP Michaelis complex, 
conformational change of the Michaelis complex, decarboxylation of OAA to form the 
enolate intermediate, phosphorylation of the enolate intermediate to form PEP, 
conformational change and final release of PEP and GDP. During the catalytic process, 
PCK stabilizes the unstable enolate intermediate to reduce the energetic cost for 
phosphoryl transfer and protects the enolate intermediate from formation of pyruvate 
(Matte et al., 1997, Carlson and Holyoak, 2009).   
Isoforms of PCK. Phosphoenolpyruvate carboxykinase has two isoforms. The 
mitochondrial form (PCK2) was first isolated from chicken liver mitochondrion in 1953, 
and the cytosolic form (PCK1) was later isolated from cytosol of rat liver in 1963 
(Nordlie and Lardy, 1963). The two isoforms of PCK are encoded by separate nuclear 
single copy genes that differ in sequence and size. In mammals, cDNAs for PCK1 from 
rat (Yoo-Warren et al., 1983, Beale et al., 1985), mouse (Williams et al., 1999), human 
(O'Brien et al., 1995), chicken (Hod et al., 1984, Cook et al., 1986), and bovine (Agca et 
al., 2002), and for PCK2 from chicken (Weldon et al., 1990) and bovine (Agca et al., 
2002) have been cloned. In bovine, the genes for PCK1 and PCK2 located at 
chromosome 13 and chromosome 10, respectively, share 58% nucleotide sequence 





core amino acid sequences of PCK1 and PCK2 coded by the respective genes share 80% 
identity and have similar protein structure in chickens (Weldon et al., 1990), and the 
molecular weight and enzyme kinetics are virtually the same for the two isoforms in all 
species (Ballard and Hanson, 1967, Hanson and Garber, 1972, Croniger et al., 2002).  
The intracellular distribution of PCK depends on species and development stage, 
and most mammals express both isoforms. Over 95% of PCK in liver of rodents is the 
cytosolic form (Nordlie and Lardy, 1963, Wiese et al., 1991, Croniger et al., 2002), and 
the activity of PCK1 in the liver of fetal rats is negligible, but increases to nearly 25-fold 
immediately after birth, whereas the activity of PCK2 is dominant only in the fetal stage 
(Ballard and Hanson, 1967). Both isoforms were expressed in developing chicken, 
whereas only the mitochondrial form was found in the adult chicken liver.  Most species 
express approximately equal activities of the two isoforms in liver, such as ruminants and 
human, yet PCK2 activity is predominant in fetal ruminants (Hanson and Garber, 1972, 
Narkewicz et al., 1993, Agca et al., 2002).  
Evolutionary Conservation. Both the nucleotide sequence and amino acid 
sequences of PCK1 have remarkable conservation among mammalian species (Hanson 
and Reshef, 1997, Yang et al., 2009). The cloned PCK1 gene sequences from rat, mouse, 
and human have over 90% similarities within the coding region of their nucleotide 
sequences (Hanson and Reshef, 1997). The promoter regions of PCK1 gene for these 
species have identical transcription factor response elements at the same relative 
positions (Yang et al., 2009). The bovine PCK1 gene sequence shares approximately 





nucleotide sequence similarity in the coding region with rat, mouse and human (Agca et 
al., 2002). However, the promoter region of PCK1 in bovine has not been characterized. 
The amino acid sequences of each enzyme have been deduced from the nucleotide 
sequences. In general, amino acid sequences of PCK1 of various species are highly 
conserved (Weldon et al., 1990, Agca et al., 2002). The translated sequence of bovine 
PCK1 encodes a 622 amino acid protein which shares 87% similarity with rat, mouse, 
and human (Agca et al., 2002). Comparison of PCK1 and PCK2 indicates a greater 
conservation of PCK1 among species, and PCK1 has been proposed as the more 
primordial form of the enzyme (Weldon et al., 1990, Agca et al., 2002).  
Cataplerotic roles of PCK  
The metabolic role of PCK is closely related to its function as a cataplerotic 
enzyme. The removal of OAA from the TCA cycle by PCK can be used to feed several 
downstream metabolic processes, including gluconeogenesis, glyceroneogenesis, and 
maintain TCA cycle activity (Figure 1.1).  
Gluconeogenesis 
Gluconeogenesis Overview. Gluconeogenesis refers to the pathway for de novo 
synthesis of glucose from non-carbohydrate precursors, including lactate, amino acids, 
glycerol and propionate (Mayes and Bender, 2003). When the dietary supply of glucose 





homeostasis and provide glucose for tissues that have an obligatory requirement for 
glucose such as brain and mammary tissue (Aschenbach et al., 2010). Another important 
function of gluconeogenesis is to prevent the negative consequences of systematic 
accumulation of lactate and propionate, i.e. lactic acidosis or propionic academia (Exton, 
1972, Aschenbach et al., 2010).  Liver is the major gluconeogenic organ, and kidney 
becomes an important site during acidosis and fasting (Exton, 1972). Small intestine has 
been recently revealed as a third gluconeogenic organ using glutamine, glycerol and 
propionate as substrates (Croset et al., 2001, Mithieux et al., 2004, De Vadder et al., 
2014). However, its relative contribution is much smaller compared to the other two 
tissues.  
Gluconeogenesis shares part of the same pathways with the TCA cycle and 
glycolysis. However, it is not a simple reversal of glycolysis because of the 
thermodynamic barriers of three non-equilibrium reactions (Mayes and Bender, 2003). 
The first barrier catalyzed by pyruvate kinase in glycolysis is circumvented by two 
endothermic reactions in gluconeogenesis, carboxylation of pyruvate to OAA by PC in 
the mitochondrion and decarboxylation of OAA to phosphoenolpyruvate (PEP) in the 
mitochondrion by PCK2 or in the cytosol by PCK1, and the relative contributions of 
these two compartments vary among species as previously mentioned. For the 
decarboxylation of OAA by PCK1, it needs to be transported to the cytosol; however, 
OAA cannot directly cross the membrane of mitochondrion. Alternatively, it is converted 
into malate and aspartate, which is transported across the mitochondrion membrane to the 





Bender, 2003).  The second barrier catalyzed by phosphofructokinase in glycolysis is 
circumvented by fructose 1, 6-bisphosphatase (FBP) to convert fructose 1, 6-
bisphosphate to fructose 6-phosphate. The third barrier catalyzed by glucokinase and 
hexokinase in glycolysis is circumvented by glucose-6-phosphatase (G6PC) to release 
free glucose from glucose-6-phosphate. Therefore, Phosphoenolpyruvate carboxykinase, 
together with PC, FBP and G6PC are the rate-limiting enzymes for gluconeogenesis.  It is 
noteworthy that G6PC is only present in liver and kidney, but not in adipose and muscle 
to prevent lost of free glucose to the blood stream from these tissues. In addition, 
ruminant liver expresses only hexokinase, and lacks glucokinase; hexokinase has a very 
low Km for glucose (Raggi et al., 1963). These unique characteristics ensure priority for 
glucose output from the ruminant liver other than extraction of glucose from blood by the 
liver.  
Gluconeogenesis in Ruminants. The significance of gluconeogenesis in 
ruminants is emphasized by the fact that dietary carbohydrates are extensively fermented 
into short-chain fatty acids (SCFA) by ruminal microbes and little exogenous glucose is 
available for ruminal animals (Reynolds et al., 1988). Even when feeding a diet 
containing high bypass rumen starch, the absorbed glucose only accounts for less than 
5% of the total glucose supply because of limitations of intestinal glucose absorption 
(Aschenbach et al., 2010). Consequently, over 90% of glucose requirements of adult 
ruminants are met by gluconeogenesis (Aschenbach et al., 2010). Liver is the central 
gluconeogenic organ, and accounts for more than 80% of the total de novo glucose 





The reliance of ruminants on gluconeogenesis is increased during lactation. 
Glucose utilized by the mammary gland during lactation accounts for approximately 60-
85% of the total glucose requirement in ruminants (Annison and Linzell, 1964). Glucose 
is required for milk lactose synthesis, a component that determines the milk yield (Barry, 
1964, Smith, 1971). The rate of de novo glucose synthesis measured with isotope tracer 
technique is positively related to milk yield in lactating cows (Aschenbach et al., 2010).  
Regulation of Gluconeogenesis. The rate of gluconeogenesis is subject to control 
by substrate availability, the activities of these key enzymes, or both (Exton, 1972). The 
activity of the key enzymes is further regulated by three mechanisms: 1) the rate of 
enzyme synthesis 2) allosteric regulation 3) covalent modification by reversible 
phosphorylation (Mayes and Bender, 2003). Glucagon (through cyclic AMP) and 
glucocorticoids secreted during starvation enhance the synthesis of the key gluconeogenic 
enzymes, and this effect is antagonized by insulin secreted in response to elevated blood 
concentration of glucose. Pyruvate carboxykinase is allosterically activated by acetyl-
CoA, and FBP is allosterically inhibited by fructose 2, 6-bisphosphate in liver. There are 
no known allosteric regulators for PCK and G6PC.  During starvation, glucagon can also 
activate fructose 2, 6-bisphosphatase by phosphorylation resulting in decreased 











Figure 1. 1. Cataplerotic role of phosphoenolpyruvate carboxykinase in liver. The 
conversation of OAA to PEP by PCK acts as a feeder reaction for carbon from the TCA 
cycle to biosynthetic processes such as gluconeogenesis and glyceroneogenesis.  In 
addition, depletion of OAA from the TCA cycle is important for maintaining TCA cycle 
activity.  Abbreviations: DHAP, Dihydroxyacetone phosphate; F6P, fructose-6-
phosphate; F1,6BP, fructose 1, 6-bisphosphate; G3P, glyceraldehyde-3-phosphate; G6P, 
glucose-6-phosphatase; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PCK, 








Gluconeogenic Precursors. Propionate, one major SCFA derived from microbial 
fermentation of carbohydrates in the rumen, is the predominant precursor for 
gluconeogenesis in ruminant species and quantitatively separates ruminants from 
nonruminants (Aschenbach et al., 2010). Contrary to non-ruminant animals, in which the 
role of gluconeogenesis is only significant during starvation, the rate of gluconeogenesis 
in ruminants is highest after feeding or with high energy intake when the ruminal 
production of propionate is the highest. In fed state, the contribution of propionate to 
gluconeogenesis is 60 to 80% (Annison and Bryden, 1999, Aschenbach et al., 2010). 
Lactate, gluconeogenic amino acids and glycerol are also used as gluconeogenic 
precursors and the relative contributions are 16 to 26 %, 11 to 16% and 0.5 to 3 % 
respectively (Aschenbach, 2010).  
During feed restriction or energy deficiency, glucose synthesis from propionate 
decreases, which may be partially made up by increased synthesis from other substrates.  
Hepatic propionate uptake and glucose output decrease by 80% and 45% respectively in 
dairy cows after 24 h of fasting (Lomax and Baird, 1983). Glucose synthesis from 
glycerol and lactate increases, which is associated with lipid mobilization during 
starvation (Lomax and Baird, 1983). The contribution from amino acids to synthesize 
glucose is increased due to depressed intake and propionate production during late 
gestation (Bell, 2000).  
A severe shortness of gluconeogenic precursors often occurs for dairy cows 
during early lactation, a time when dramatic increased glucose requirement for lactation 





the absolute propionate uptake by liver at 4-wk after parturition doubles that at 2-wk 
before parturition, accompanied by doubled glucose output from the liver, the relative 
contribution of propionate to the total glucose synthesis is slightly reduced during the 
first week of lactation (Aschenbach et al., 2010). Gluconeogenesis from lactate, alanine, 
and glycerol increases to support lactation. Glycerol generated during adipose tissue 
mobilization can meet 15-20% of glucose requirement (Bell, 1995).  Feeding strategies 
aimed at increasing exogenous gluconeogenic precursors have been shown to be 
beneficial for dairy cows during early lactation. These strategies include increasing feed 
intake, modification of ruminal fermentation pattern to favor propionate production and 
direct supplementation of glucogenic substrates, i.e. sodium propionate, propylene glycol 
and glycerol (Overton and Waldron, 2004, Aschenbach et al., 2010).  
Regulation of Precursor Entry to Gluconeogenesis. The first committed step for 
gluconeogenesis is conversion of OAA to PEP by PCK, and OAA is a common point for 
entry of different precursors to gluconeogenic pathway, except a special case where 
glycerol does not depend on PCK and enters the gluconeogenic pathway from G3P.  
Lactate and alanine are first converted to pyruvate in the cytosol, which is transported 
into the mitochondrion and converted to OAA by PC.  Propionate is first catalyzed to 
propionyl-CoA by propionyl-CoA carboxylase (PCoAC), which is converted by 
methylmalonyl-CoA mutase (MCM) to succinyl-CoA and forms OAA through part of the 
TCA cycle (Aschenbach et al., 2010).  Even though PCoAC and MCM have been 
proposed as potential regulating points for propionate entry to gluconeogenesis, limited 





transcriptional or translational regulations (Aschenbach et al., 2010).  Instead, the activity 
of PCK is the key enzyme for controlling the rate of de novo glucose synthesis from 
propionate (Hanson and Garber, 1972). The presence of PCK activity in both 
mitochondrion and cytosol extends the possibilities for regulation of use of different 
substrates for gluconeogenesis. Following conversion of OAA to PEP via PCK, the 
subsequent reduction of 1, 3-diphosphoglycerate in the cytosol has an absolute 
requirement for NADH. Lactate can generate NADH during its conversion to pyruvate in 
the cytosol. However, the conversion of propionate and some amino acids to PEP 
requires synthesis of NADH in the cytosol, and malate functions as both a carrier of OAA 
for gluconeogenesis and reducing equivalents (Hanson and Garber, 1972, Aschenbach et 
al., 2010). Accordingly, current wisdom is that entry of lactate to gluconeogenesis is 
regulated via PC and PCK2 activity, entry of amino acids via PC and PCK1 activity, and 
entry of propionate via PCK1 activity (Agca et al., 2002, Aschenbach et al., 2010).  
Physiological Role of PCK1 in Gluconeogenesis. The molecular tools to modify 
the expression of PCK1 in specific tissues have advanced our understanding of the 
metabolic role of this enzyme. Glucose production in perfused liver isolated from liver-
specific PCK1 knockout mice is reduced by 50% compared with the liver isolated from 
wild-type mice, and the reduction is because of severe impaired gluconeogenesis from 
PEP, whereas gluconeogenesis from glycerol is not altered (Burgess et al., 2004). 
Likewise, liver-specific deletion of the PCK1 gene in mice results in a great reduction of 
gluconeogenesis in liver, decreased glycogen stores in liver, and muscle and whole body 





concentration during 36 h-fasting, indicating gluconeogenesis in kidney may be able to 
maintain glucose homeostasis during this critical period, but mice with global deletion of 
PCK1 die of severe hypoglycemia within several days after birth (She et al., 2000, She et 
al., 2003). Human infants born with a PCK1 deficiency experienced neonatal 
hypoglycemia and early death despite of the normal activity of PCK2 (Vidnes and 
SØVik, 1976).  On the other hand, overexpression of PCK1 in the liver of mice results in 
a significant increase in hepatic glucose production, and the development of insulin-
dependent diabetes mellitus (Valera et al., 1994). 
Glyceroneogenesis 
 Glyceroneogenesis, commonly described as the abbreviated version of 
gluconeogenesis, is the synthesis of 3-glycerol phosphate from gluconeogenic precursors 
except glycerol (Reshef et al., 2003). In mammals, approximate 75% of the free fatty 
acids (FFA) released from white adipose tissue during lipolysis is recycled and 
condensed with 3-glycerol phosphate to reform triglycerides (Reshef et al., 2003). The 
FFA/triglyceride cycling occurs both locally in white adipose tissue and systematically in 
liver where the FFA are re-esterified to triglycerides and packed and released as very low 
density lipoprotein (VLDL).  It is interesting that the contribution of plasma glycerol to 
the synthesis of 3-glycerol phosphate in liver is negligible during fasting even though 
there is considerable glycerol kinase activity in liver (Reshef et al., 2003).  
Phosphoenolpyruvate carboxykinase catalyzes the rate-limiting step of 





glyceroneogenesis in white adipose tissue is to restrain FFA release, whereas the function 
in liver is to promote synthesis of triglycerides that can be exported as the form of VLDL 
out of the liver (Reshef et al., 2003). The critical role of PCK1 in glyceroneogenesis in 
white adipose tissue is demonstrated by the abolishment of PCK1 gene expression in 
white adipose tissue of mice, which totally eliminates the synthesis of glyceride-glycerol 
from pyruvate, and reduced triglyceride content in adipose tissue (Olswang, 2002). Both 
liver-specific and global deletion of PCK1 result in accumulation of triglyceride and fatty 
acids in liver (She et al., 2000), and the development of fatty liver by liver-specific PCK1 
deletion is at least partially because of the impaired hepatic glyceroneogenesis, and 
altered fatty acids re-esterification (Croniger et al., 2002). Glyceroneogenesis is 
important for lipid metabolism in ruminants because glucose requirements are largely 
met by gluconeogenesis, and glucose is at premium for these animals and is not used for 
3-glycerol phosphate synthesis.  
TCA Cycle Activity 
The TCA cycle includes a series of reactions in the mitochondrion that oxidizes 
acetyl-CoA to CO2 and provides a substrate for the respiratory chain to generate ATP. It 
is the merging pathway for carbohydrate, lipid and protein oxidation and also plays an 
essential role in gluconeogenesis, lipogenesis, and synthesis of nonessential amino acids 
(Murray et al., 2003).  
The initial reaction of the TCA cycle is the condensation of two-carbon acetyl-





Two molecules of CO2 are produced and OAA is regenerated at each TCA cycle. A large 
quantity of acetyl-CoA can be oxidized in the presence of a small quantity of OAA 
(Murray et al., 2003). The pool size of OAA is relatively consistent during low energy 
intake or high energy consumption such as exercise, but can increase significantly during 
feeding (Owen et al., 2002). Removal of OAA from the TCA cycle via the cataplerotic 
enzyme PCK is required because the TCA cycle cannot serve as a carbon sink (Owen et 
al., 2002). The pool of TCA cycle intermediates such as OAA impacts the TCA cycle 
capacity (Owen et al., 2002).  The OAA pool is determined by the relative activity of 
PCK and PC.  
Liver-specific PCK1 knockout mice have 2-fold lower glucose production 
because of the complete blockage of gluconeogenesis from TCA cycle intermediates. 
Interestingly, these mice are able to maintain euglycemia through gluconeogenesis from 
glycerol and in kidney, but develop severe hepatic steatosis because of the impaired 
hepatic cataplerosis, characterized by accumulation of TCA cycle intermediates, greatly 
reduced TCA cycle flux, and inhibition of fatty acid oxidation (Burgess et al., 2004). 
Therefore, the impaired cataplerosis in liver of animals can lead to detrimental effects on 
energy metabolism. Additionally, it is noteworthy that impaired anaplerosis and reduction 
in OAA pool, caused by increased PCK activity or decreased PC activity, for example, 
may also inhibit the oxidative capacity of the TCA cycle. Taken these together, a 






Physiological control of PCK activity  
The total cellular activity of PCK is determined by the synthesis and degradation 
of the enzyme because of lack of allosteric regulation of either isoforms of the PCK. The 
level of PCK1 is regulated by a variety of dietary and hormonal stimuli according to 
physiological needs. The half-life of PCK1 protein is 6 to 8 hours, and the degradation of 
PCK1 has been considered to be lack of regulation for a long time, until a recent study 
indicated that the stability of PCK1 is regulated by acetylation, a process that is 
controlled by different nutrients (Jiang et al., 2011). Glucose increases degradation of 
PCK1 by activating acetylation, whereas amino acids decrease PCK1 degradation by 
inhibiting its acetylation (Jiang et al., 2011).  The half-life of PCK2 protein in chickens is 
much longer (48 days), and synthesis of PCK2 is generally considered constitutive and 
lacks dietary and hormonal control. However, a much more remarkable induction (43-
fold) of PCK2 activity is observed in the mammary tissue of guinea pigs during transition 
to lactation compared to an 11-fold induction of PCK1activity. The metabolism role of 
PCK2 and its potential regulation may have been over-simplified during the past decades 
and remains elusive.  
In contrast to the relative ignorance of PCK2, the regulation of PCK1 synthesis in 
various tissues has been extensively studied, and is under acute control by various 
nutritional and hormonal stimuli. Synthesis of PCK1 in the liver of monogastric animals 
is increased by starvation and decreased by a high-carbohydrate diet.  Glucagon (acting 





insulin dominantly represses these inductions.  Dietary glucose may repress PCK1 
synthesis through elevating insulin concentration, but may also have a repressive effect 
independent of insulin. It is also clear that these hormonal and dietary regulations of 
PCK1 synthesis are primarily determined by the transcription of the PCK1 gene.  
The regulations of PCK synthesis in ruminants are in contrast to that in 
monogastric animals in many aspects. In ruminants, hepatic PCK1 mRNA expression is 
not induced during feed restriction; instead, it is induced when feed intake is increased 
(Greenfield et al., 2000), and increased by glucagon in a time dependent manner (Bobe et 
al., 2009). Glucagon increases PCK1 mRNA in liver at day 11 and day 15, but not at day 
22 after parturition (Bobe et al., 2009). Compared to other mammals, ruminants are 
known to be more insulin resistant, especially during early lactation, which may be 
related to a greater reliance on gluconeogenesis to meet glucose requirements. However, 
the potential unique transcriptional regulation of PCK1 synthesis by dietary and 
hormonal factors in bovine has not been characterized.  
Regulation of PCK1 transcription  
The expression of the PCK1 gene is determined by the rate of transcription and 
degradation of its mRNA. The responses of PCK1 transcription to hormones is rapid; a 
10-fold induction by cyclic AMP (cAMP) in rat liver is observed within 20 min (Lamers 
et al., 1982), and addition of insulin results in a 50% decrease in PCK1 mRNA 





rapid, with a 30 min half-life when the gene is not transcribed (Nelson et al., 1980). The 
stability of PCK1 mRNA is increased by cAMP in liver (Hod and Hanson, 1988), and by 
metabolic acidosis in kidney (Kaiser and Curthoys, 1991), two factors that also increase 
PCK1 transcription in the respective tissue. An overall increase in PCK1 mRNA 
abundance directly results in elevated synthesis of the PCK1 protein, which determines 
the activity of this enzyme (Yang et al., 2009).  
Promoter of PCK1 
The transcription of the PCK1 gene is regulated by binding of various 
transcription factors and co-factors to specific response elements within its promoter in 
response to hormonal and dietary stimuli (Hanson and Reshef, 1997).  The promoter of 
the PCK1 gene has been most extensively studied in rat. A promoter region of the rat 
PCK1 gene from -460 to +73 bp relative to the transcription start site (TSS) was 
originally identified to contain eight protein binding sites by DNase I footprinting 
analysis using nuclear proteins extracted from the rat liver. The eight sites were named as 
P1, P2, P3 (I), P3 (II), P4, P5, P6, and a cAMP response element (CRE) (Roesler et al., 
1989). A broader promoter region of PCK1 gene from -4800 to +73 bp relative to the 
TSS has been studied and many accessory factor (AF) binding sites (i.e. AF1, AF2) have 
been identified; regulatory elements within a region between -1500 to +73 bp are 
responsible for the hormonal and dietary regulation of PCK1 gene transcription in the 
liver (Chakravarty et al., 2005). The binding of transcription factors to the regulatory 





P6 sites are bound by nuclear protein extracted from kidney (Roesler et al., 1989), and 
CRE-1, P1, P3, P4, and P6 sites are bound by nuclear protein extracted from white 
adipose tissue (Hanson and Reshef, 1997).  
The basal transcription of PCK1 requires different cis-regulatory elements in 
different tissues. In liver, it requires interaction of CRE-1 and P3 (I), as mutation each 
individual site only slightly decreased the expression, whereas double deletions of these 
two sites significantly decreased its transcription (Liu et al., 1991). In contrast, the 
expression of PCK1 in kidney is enhanced by mutation of P3(I); the mutation of P2 site 
greatly reduced the renal expression of PCK1 (Hanson and Reshef, 1997). More than a 
dozen regulatory elements or units (several elements work together) have been identified 
within the rat promoter that when bound to different transcription factors, are responsible 
for the tissue-specific expression of PCK1 and its regulation by a variety of hormones 
and nutrients (Chakravarty et al., 2005).  
In order to gain more information about the regulation of PCK1 transcription in 
other vertebrate species, the promoter regions from -1000 bp of 5’ sequence to the TSS of 
the PCK1 gene in mouse, human, dog, chicken, and cow were aligned to the 
corresponding region of rat in a previous study (Yang et al., 2009). A number of highly 
conserved regions with greater than 95% sequence identity have been identified, and 
these regions directly correspond to the binding sites of known transcription factors 
within the promoter region of rat PCK1, including the cAMP response element (CRE), 
hepatic nuclear factor 4 alpha (HNF4α), CAAT/enhancer-binding protein (C/EBP), 





These transcription factors and their binding sites are critical in differentially mediating 
the transcription of PCK1 gene in response to hormonal and dietary stimuli.  Meanwhile, 
the occurrence and position of some transcription factor binding sites, i.e. sterol 
regulatory element-binding protein -1c (SREBP-1c), within the PCK1 promoter is 
considerable variable among species. This transcription factor is involved in regulating 
the responsiveness of PCK1 transcription to insulin and the variability among species, i.e. 
between rat and cow, may be related to the differences among species in the regulation of 
PCK1 activity and gluconeogenesis by insulin.  It is noteworthy that direct cross-species 
application regarding the regulations of PCK1 transcription by hormones and nutrients 
must be done with caution, as the direct analysis of PCK1 promoter in bovine and its 
regulation are not yet available.  
Hormonal Regulation of PCK1 Transcription 
Regulation by Cyclic AMP. Glucagon, as one major hormone that induces PCK1 
transcription in the liver, acts through elevated intracellular cAMP level, and subsequent 
activation of protein kinase A (PKA). The initial characterization of regulatory elements 
within the promoter of the rat PCK1 gene revealed a palindromic sequence 5’- 
TGACGTCA-3’ located at -85 bp relative to the TSS, termed CRE (Short et al., 1986). It 
is typically a binding site for CRE binding protein (CREB), which can be phosphorylated 
by activated PKA in response to elevated cAMP level, and binds to its co-activator 
CREB binding protein (CBP), leading to induction of PCK1 transcription (Chrivia et al., 





expressed and it is difficult to explain the tissue-specific induction of PCK transcription 
by cAMP.  The transcription of PCK1 is strongly induced by cAMP in liver, but weakly 
induced in kidney (Lamers et al., 1982, Meisner et al., 1985).  One study identified the P3 
(I) site (-250 to -234 bp) cooperates with CRE to mediate cAMP induction (Liu et al., 
1991). Later research further suggested a cAMP response unit consisting of CRE and 
another four cis-regulatory elements within the region -330 to -230 bp are responsible for 
the full responsiveness of rat PCK1 to cAMP (Roesler, 2000). The four cis-elements are 
three C/EBP binding sites and an AP-1 element (Roesler, 2000). Binding of either CREB 
or C/EBPα to CRE is able to synergize with the other four cis-elements to mediate the 
induction of PCK1 by cAMP (Roesler et al., 1995, Roesler et al., 1998). The binding of 
CREB to CRE and C/EBPα to the three distal C/EBP binding sites ensures the maximum 
induction, whereas substitution of CREB with C/EBPα to bind CRE and/or substitution 
of C/EBPα with C/EBPβ to bind the distal C/EBP binding sites results in lower 
responsiveness. Binding of CRE with C/EBPβ or the incomplete or absent occupancy of 
the three distal C/EBP binding sites leads to weak responsiveness of PCK1 to cAMP 
(Roesler, 2000). The binding of different transcription factors to the same cis-elements 
allows tissue-specific regulation of PCK1 by cAMP. Changes in expression of the two 
isoforms of C/EBP in response to different stimuli may influence the responsiveness of 
PKC1 transcription to cAMP (Roesler, 2000).  
Regulation by Glucocorticoids. Glucocorticoid is another major hormone that 
plays a critical role in regulating PCK1 transcription in a tissue-specific manner. 
Transcription of PCK1 gene is induced by glucocorticoids in liver and kidney cortex, but 





al., 2005).  Similar to the requirement of CRU to mediate cAMP-induced PCK1 gene 
transcription, a glucocorticoid regulatory unit (GRU), instead of a single glucocorticoid 
regulatory element (GRE) within the PCK1 promoter is involved in the hepatic regulation 
of PCK1 transcription by glucocorticoids. The concept of a GRU has been introduced and 
refined during the past 25 years, and the promoter region used to characterize the GRU 
has been extended from a region between -600 and +68 bp to a region between -2000 to 
+73 bp (Imai et al., 1990, Wang et al., 1996, Scott et al., 1998, Cassuto et al., 2005).  An 
extended GRU has been proposed, which consists of two GREs, four accessory factor 
binding sites, as well as CRE (Chakravarty et al., 2005). The four AF include two 
proximal AF1 and AF2, and their distal counterpart dAF1 (-993 bp) and dAF2 (-1365 
bp).The hepatic induction of PCK1 transcription by glucocorticoids involves a 
conformational bend of the DNA region of the four AF to form a palindrome, which 
facilitates the recruitment of required TF into the GRU (Cassuto et al., 2005). Addition of 
dexamethasone to hepatocytes leads to increased binding of glucocorticoid receptor (GR) 
to GRE, binding of HNF4α and C/EBPα to the dAF1 site and the CRE respectively, and 
PPARα to the AF2 site (Chakravarty et al., 2005).  
The presence of both cAMP and dexamethasone stimulates PCK1 expression to a 
greater extent than each individual hormone in rat hepatocytes (Salavert and Iynedjian, 
1982), which is mainly attributed to the significant increase in binding of C/EBPα and 
C/EBPβ to the CRE and P3(I) site (Chakravarty et al., 2005).  
Regulation by Insulin. Insulin rapidly and dominantly represses the stimulated 
transcription of PCK1 gene in the rat liver (Granner et al., 1983, Sasaki et al., 1984, 





and dexamethasone is reduced by insulin in H4IIE hepatoma cells (Magnuson et al., 
1987). The mechanism for the dominant inhibition of PCK1 transcription by insulin is 
more elusive compared to cAMP and glucocorticoids. It involves a number of signaling 
pathways initiated by insulin, and a set of transcription factors and co-regulatory proteins 
that bind to an array of sites in the promoter of PCK1 gene (Hanson and Reshef, 1997, 
Chakravarty et al., 2005). In general, insulin is able to modify the pattern of transcription 
factor binding caused by cAMP and glucocorticoids. In represented of insulin, the 
binding of C/EBPα and C/EBPβ to the CRE and P3 (I) region, and binding of HNF4Αto 
the AF2 site are totally abolished (Chakravarty et al., 2005). One putative insulin 
responsive element (IRS) has been identified in the promoter of rat PCK1 gene (O'Brien 
et al., 1990, O'Brien and Granner, 1996). This IRS is located from -413 to -407 bp 
relative to TSS and has an overlap with AF2 sites of the GRU. However, the mutation of 
this IRS only leads to a 50% decrease in the repressive effects of insulin on PCK1 
transcription. It has been suggested that two SREBP-1 binding sites (SRE) identified at -
590 and -322 bp in the PCK1 promoter are also involved in mediating insulin repression 
of PCK1. Addition of insulin leads to increased expression of SREBP-1 and its binding to 
SRE in hepatocytes; double mutation of these two sites eliminates the inhibition of PCK1 
transcription (Chakravarty et al., 2004, Chakravarty et al., 2005). The transcription factor 
SREBP-1 is involved in lipid and carbohydrate metabolism, which is partially due to its 
acute response to insulin to mediate repression of PCK1 transcription (Chakravarty and 
Hanson, 2007).  
In summary, the transcription of rat PCK1 gene, especially in rat liver has been 





characterized eukaryote gene promoters. Most of the studies have been focused on the 
region from -1500 to +73 bp relative to TSS, a region that contains many important cis-
regulatory elements that are responsible for hormonal and dietary regulations. Conserved 
cis-regulatory elements have been discovered among different vertebrate species; 
however, the functional analysis of these putative cis-elements in the promoter region of 
bovine PCK1 and the corresponding transcription factors that mediate the responses to 
hormonal and dietary stimuli have not been demonstrated yet.  
Regulation of PCK1 and G6PC Transcription by Short-Chain Fatty Acids 
Short-chain fatty acids production in ruminants. Short-chain fatty acids, also 
known as volatile fatty acids, are major end products of ruminal microbial fermentation 
of carbohydrates, and provide about 60 to 80% of metabolizable energy for ruminants 
(Bergman, 1990).  Acetate, propionate and butyrate are quantitatively important SCFA 
(Kristensen et al., 1998). The concentrations of acetate and propionate in the rumen are 
highly variable, depending on dietary composition. A grass-based diet results in 70% 
acetate and 20% propionate as the molar proportions of the total SCFA. In contrast, a 
grain-based diet rich in starch yields 50% acetate, and 40% propionate. The percentage of 
butyrate is relatively constant (10%) for both diets (Bergman, 1990).  
Butyrate is extensively metabolized by the ruminal epithelium as an energy 
source; only 18 to 52% is released to the portal vein, of which 80% is then taken up by 
liver and converted to acetyl-CoA, ketone bodies or long chain fatty acids (Bergman, 





epithelium is negligible, and acetate is fully recovered in the portal vein, but instead of 
being taken up by liver, it is mainly metabolized by the peripheral tissues such as muscle, 
adipose tissue and mammary gland (Bergman, 1990, Kristensen et al., 1998, Kristensen, 
2005).  Approximate 91 to 95% of propionate produced in the rumen is recovered in the 
portal vein, of which over 90% is efficiently taken up by the liver (Kristensen, 2005, 
Nozière et al., 2010). Among the three major SCFA, propionate is the only one that is 
used as a gluconeogenic precursor, and over 90% of propionate taken up by the liver is 
utilized for de novo glucose synthesis (Lomax and Baird, 1983, Armentano, 1992, 
Annison and Bryden, 1999).  
Biological and physiological role of SCFA. Short-chain fatty acids are not only a 
direct nutrient source for animals, but also act as signaling molecules to regulate a range 
of cellular processes and physiological functions, such as regulation of cell proliferation 
and apoptosis,  carbohydrate and lipid metabolism, insulin secretion, immune responses 
and inflammation (Ulven, 2012, Layden et al., 2013, Natarajan and Pluznick, 2014), and 
have positive effects on regulation of glucose homeostasis, prevention of high-fat diet-
induced obesity, and suppression of tumor formation (Ulven, 2012, Layden et al., 2013).   
A large number of genes involved in different biological and metabolic pathways 
in various tissues are subjected to regulation by SCFA, including acetate, propionate, and 
butyrate in nonruminants (Tedelind et al., 2007, Alvaro et al., 2008, Bhatia et al., 2009), 
and in ruminants (Lee and Hossner, 2002, Soliman et al., 2007, Hosseini et al., 2012).  
Regulation of gluconeogenic genes by SCFA, including propionate and butyrate, has 





De Vadder et al., 2014). The mechanism by which SCFA induces expression of 
gluconeogenic genes includes G-protein-coupled receptors (GPCR), and several 
transcription factors and co-factors including HNF4α, PGC-1, and CREB (Herzig et al., 
2001, Yoon et al., 2001, Brown et al., 2003, Massillon et al., 2003, Gonzalez, 2008).  
Regulation by G-protein-coupled receptors. Short-chain fatty acids have been 
recently identified as ligands for GPR41 and GPR43, also known as free fatty acid 
receptor  (FFAR) 3 and FFAR2 respectively (Brown et al., 2003, Layden et al., 2013). 
These two types of receptors have a ubiquitous expression throughout the human body 
(Tang et al., 2012) and bovine tissues (Wang et al., 2009, Yonezawa et al., 2009). Free 
fatty acid receptor 2 preferentially binds to acetate and propionate, whereas FFAR3 has a 
preference for propionate and butyrate. Upon activation by their ligands, GPCR that are 
comprised of α, β, and γ subunits stimulate downstream signaling through the one of the 
subunits, and most well-studied pathways are mediated by the α subunit, including Gαs, 
Gαi, Gαq, and Gα12. So far, it has been shown that FFAR2 couples both Gαi and Gαq, 
whereas FFAR3 couples to Gαi (Hirasawa et al., 2008).  The ability of SCFA in 
stimulating adipogenesis and inhibiting lipolysis through receptor activation have enabled 
FFAR2 and FFAR3 therapeutic targets to treat metabolic disease, such as diabetes, 
obesity and dyslipidemia (Blad et al., 2012, Ulven, 2012). 
The induction of intestinal expression of PCK1 and G6PC mRNA by propionate 
in rat is mediated via a gut-brain neural axis mechanism involving FFAR3 in the portal 
nerves (De Vadder et al., 2014). Propionate-induced granule release from isolated bovine 





Increased leptin production by SCFA is through activation of FFAR3 in mice adipocytes 
(Xiong et al., 2004). Short-term intravenous propionate infusion increases FFAR3 mRNA 
expression in the subcutaneous adipose tissue in goats (Mielenz et al., 2008). The hepatic 
expression of FFAR3 and FFAR2 may have significant metabolic relevance, considering 
propionate and butyrate are highly metabolized in liver. Even though hepatic expression 
of FFAR2 and FFAR3 has been described in rodents (Bindels et al., 2013), human 
(Hirasawa et al., 2008), porcine (Li et al., 2014), and bovine (Wang et al., 2009), limited 
information is available regarding their role in mediating gene expression in liver.  
Regulation by HNF4α. The transcription factor HNF4α belongs to the nuclear 
receptor superfamily and is expressed most abundantly in liver, and at lower levels in 
kidney and intestine (Zhong et al., 1994, Jiang et al., 1995). Upon binding to its 
recognition sites in the promoter of its target gene as a homodimer, HNF4α recruits other 
transcription factors and coactivators to regulate the expression of a large number of 
target genes involved in hepatocyte differentiation, glucose, fatty acid, and cholesterol 
metabolism, ureagenesis and bile acid synthesis (Sladek et al., 1990, Liu and Towle, 
1995, Watt et al., 2003, Gonzalez, 2008, Babeu and Boudreau, 2014). The binding sites 
of HNF4α within the promoter of PCK1 and G6PC gene in rats have been identified 
(Hanson and Reshef, 1997, Massillon et al., 2003, Chakravarty et al., 2005), and the 
regulation of these two genes by HNF4α requires a coactivator PGC-1α (Gonzalez, 
2008).  
The critical role of HNF4α in stimulating expression of  PCK1 and G6PC genes 





concentrations, is well documented (Gonzalez, 2008). Additionally, HNF4α plays an 
important role in regulation of PCK1 and G6PC gene expression by nutritional cues. The 
induction of rat G6PC transcription by SCFA requires binding of HNF4α to its promoter, 
and in the presence of a dominant negative HNF4α, induction is eliminated (Massillon et 
al., 2003). On the other hand, overexpression of HNF4α in rat H4IIE cells increases 
G6PC transcription and this effect is synergistically amplified by hyperacetylation caused 
by inhibition of the histone deacetylase (Massillon et al., 2003).  Polyunsaturated fatty 
acids repress G6PC transcription in Hela cells, which is achieved through removing 
HNF4α from its binding sites in the promoter of rat G6PC (Rajas et al., 2002).  
The activity of HNF4α is controlled at both transcriptional and posttranscriptional 
levels. By phosphorylation at different Ser residues, the capacity of HNF4α to regulate its 
target genes can be either positively regulated through increased binding affinity to co-
activators and the regulatory DNA elements, or negatively regulated through its 
translocation from the nucleus to the cytoplasm and increased degradation (Gonzalez, 
2008).  Additionally, transcription of HNF4α is induced by cAMP-PKA-CREB signaling 
cascade in HepG2 cells (Dankel et al., 2010), a common signaling pathway in response to 
elevated glucagon concentration during starvation. Propionate and butyrate are able to 
induce HNF4α transcription (Guan et al., 2011), which may be also mediated by 
activation of cAMP-PKA-CREB signaling pathway in Caco-2 cells (Wang et al., 2012). 
Indeed, butyrate induces expression of rat intestinal PCK1 and G6PC mRNA through a 





Regulation by PGC-1α. The transcriptional coactivator PGC-1α, the first member 
of the  PGC-1 family, was initially isolated from murine brown fat cells as a novel 
binding protein of PPARγ to regulate adaptive thermogenesis (Puigserver et al., 1998). 
Since then, a number of transcription factors have been revealed as the targets of PGC-1α 
that is expressed in various tissues, including liver, skeletal muscle, heart and brain. 
Through interacting with different transcription factors, PGC-1α regulates a number of 
metabolic and biological processes, such as hepatic gluconeogenesis, ketogenesis and 
fatty acid oxidation in liver (Herzig et al., 2001, Yoon et al., 2001, Lin et al., 2005) and 
fiber type switching in skeletal muscle (Lin et al., 2002).  
The coactivator PGC-1α is a critical regulator of gluconeogenesis in liver, and is a 
major target for acute regulation by hormonal cues (Yoon et al., 2001).  Expression of 
exogenous PGC-1α at physiological levels induces the mRNA expression of PCK1 and 
G6PC and increases glucose production both in mice liver and in primary hepatocytes 
(Yoon et al., 2001). The mRNA expression of PGC-1α is induced along with increased 
expression of HNF4α, PCK1 and G6PC in fasting or insulin-deficient diabetes mice 
(Yoon et al., 2001).  Consistent with the hormonal regulation of PCK1 and G6PC, PGC-
1α mRNA expression is increased by cAMP and dexamethasone, and synergistically 
induced by the combination of cAMP and dexamethasone in primary rat hepatocytes 
(Yoon et al., 2001).  The coactivator PGC-1α interacts with its target  transcription 
factors, such as HNF4α, GR, the Forkhead box protein O1 (FOXO1), and CREB to 
actively regulate hepatic gluconeogenic gene expression (Herzig et al., 2001, Yoon et al., 
2001, Puigserver et al., 2003).  An LXXLL motif within the coactivator PGC-1α has been 





While PGC-1α is required for regulating hepatic gluconeogenesis, and PGC-1α 
deficient mice generated using PGC-1α RNA interference develop hypoglycemia (Koo et 
al., 2004), abnormally elevated PGC-1α is also likely to play an important role in the 
disease state, such as hyperglycemia, diabetes, and insulin resistance.  
Regulation by CREB. The cAMP response element binding protein is a 
ubiquitously expressed transcription factor that induces transcription of target genes 
through their promoters at CREs (Mayr and Montminy, 2001). Functional CREs are 
commonly localized within 250 bp of the TSS in approximately 5,000 genes of the 
mammalian genome (Altarejos and Montminy, 2011). At least one CRE has been 
identified in the proximate promoter of PCK1 and G6PC (Schmoll et al., 1999, Roesler, 
2000). In response to hormonal stimuli such as glucagon and catecholamines that elevate 
intracellular cAMP level, CREB is phosphorylated by PKA to its active form to regulate 
its target gene, such as PCK1 and G6PC, by binding to the CRE in their promoters (Liu et 
al., 1991, Altarejos and Montminy, 2011). The requirement of CREB for gluconeogenesis 
is demonstrated by the fact that mRNA expression of gluconeogenic genes including 
PCK1, G6P, and PC are significantly reduced in CREB-deficient mice who suffer 
hypoglycemia (Herzig et al., 2001).  Cotransfection of a dominant negative CREB 
protein into HepG2 cells blocked the induction of PCK1 promoter transcription by cAMP 
(Herzig et al., 2001). The role of CREB in stimulating hepatic gluconeogenic gene 
transcription is through a directly induced transcription of PGC-1α as a downstream 
target of CREB to promote gluconeogenesis in liver (Herzig et al., 2001, Altarejos and 





Additionally, the function of CREB in mediating target gene transcription is 
modulated by interaction with CREB binding protein (CBP) and CREB-regulated 
transcriptional coactivator (CRTC) (Altarejos and Montminy, 2011). The coactivator 
CRTC is activated by dephosphorylation in response to elevated cAMP and translocated 
from the cytosol to the nucleus to facilitate CREB to regulate the transcription of target 
genes, including PCK1 and G6PC (Altarejos and Montminy, 2011, Jitrapakdee, 2012). 
The coactivator CBP has histone acetyltransferase activity and is involved in chromatin 
remodeling and coactivation of many transcription factors (Altarejos and Montminy, 
2011).  
Histone acetylation is an important posttranslational modification that regulates 
the activity of many transcription factors that regulate gluconeogenic gene transcription 
(Soutoglou et al., 2000). The accessibility of transcription factors to nucleosomal DNA is 
increased by histone acetylation (Struhl, 1998, Soutoglou et al., 2000). The coactivator 
CBP is one of the transcription factor co-activator proteins that has intrinsic histone 
acetyltransferase activity, and plays an important role in the transcriptional activation of 
many genes (Shiama, 1997). In addition to histone acetylation, CBP is also able to 
acetylate other proteins, including HNF4 family. Acetylation of HNF4 by CBP induces a 
conformational change on HNF4 to increase its affinity for the target gene and prevent its 
active export from the nucleus to the cytoplasm, which is required for HNF4 to activate 
the transcription of hepatic genes (Soutoglou et al., 2000).  
While the recent discovery of SCFA as ligands of GPCR gains more and more 





mechanisms. Short-chain fatty acids can be transported into a cell by non-ionic diffusion 
or transporter facilitated mechanism (Moschen et al., 2012), and act as important 
epigenetic modulators by increasing histone acetylation through inhibition of deacetylase 
activity (Boffa et al., 1978, Yoshida et al., 1990, Natarajan and Pluznick, 2014). The 
transcription of PCK1 and G6PC in rat hepatocytes and H4IIE hepatoma cells is induced 
by propionate and butyrate via increasing histone acetylation (Massillon et al., 2003).  
Role of PCK1 in disease states  
Type 2 Diabetes Mellitus and Obesity 
Type 2 diabetes mellitus (T2DM) is a genetic disease that is associated with a 
large number of candidate genes identified by large genome-wide scans (Elbein, 2002). 
One of the candidate genes is PCK1, whose transcription is closely controlled by 
hormonal and nutritional stimuli. Any mutation that alters the regulatory region of PCK1 
and increases its expression could result in elevated enzyme activity, which increases 
gluconeogenesis in liver and kidney and potentially causes T2DM. Transgenic mice that 
express PCK1 gene lacking the entire upstream regulatory region, develop fasting 
hyperglycemia and hyperinsulinemia, impaired glucose tolerance and increased body 
weight (Rosella et al., 1995).  Overexpression of PCK1 gene driven by a promoter that 
does not contain insulin responsive element into rat hepatoma H4IIE cells has increased 
gluconeogenesis which is not repressed by insulin (Rosella et al., 1993). Therefore, the 





(Hanson, 2009). Deletion of the GRE within the PCK1 promoter eliminates the induction 
of PCK1 transcription by glucocorticoids in the liver of diabetic mice (Friedman et al., 
1993).  
It has been recently emphasized that PCK1 is involved in T2DM not only through 
its role in gluconeogenesis in liver and kidney, but also through glyceroneogenesis and 
regulation of FFA/triglyceride cycling in adipose tissue and liver. Under-expression of 
PCK1 in white adipose tissue leads to reduced FFA re-esterification, and increased 
circulating FFA, which causes insulin resistance and T2DM (Beale et al., 2004).  
Additionally, PCK1 has been reported as an obesity gene. Overexpression of 
PCK1 gene in adipose tissue is associated with obesity due to increased 
glyceroneogenesis and FFA re-esterification in the adipose tissue of transgenic mice 
without development of insulin resistance (Franckhauser et al., 2002).  
Ketosis and Fatty liver 
Dairy cows often experience negative energy balance during early lactation when 
the dramatically increased nutrient requirements cannot be met by feed intake (Bell, 
1995, Drackley, 1999). During negative energy balance, FFA are extensively mobilized 
from adipose tissue and transported to the liver where these FFA are metabolized through 
four metabolic pathways: 1) metabolized through β-oxidation to acetyl-CoA which is 
completely oxidized through the TCA cycle; 2) metabolized through β-oxidation to 
acetyl-CoA which is incompletely oxidized into ketone bodies; 3) re-esterified into 





into VLDL and released from the liver; (Grummer, 1993, Bobe et al., 2004, van Knegsel 
et al., 2005).  
The elevated production of acetyl-CoA during the periods of extensive fatty acid 
mobilization may exceed the capacity of the TCA cycle for complete oxidation and needs 
to be metabolized through alternative pathways. Unlike nonruminants, dairy cows have 
limited ability to export triglycerides as VLDL because of the low levels of 
apolipoprotein A-I, apolipoprotein B, and protein kinase C that are required for 
packaging and excretion of VLDL (Grummer, 1993, Bobe et al., 2004). Therefore, the 
rate of ketogenesis and synthesis of triglycerides for storage are increased; this places 
dairy cows at high risk to develop ketosis and fatty liver.  
The capacity of the TCA cycle to completely oxidize acetyl-CoA is determined by 
the size of OAA pool (Owen et al., 2002). Either accumulated OAA or depleted OAA 
pool inhibits the TCA cycle activity and thus the complete oxidation of acetyl-CoA 
(Owen et al., 2002). For example, ketosis has been observed to be associated with 
increased gluconeogenesis and depletion of OAA pool from the TCA cycle (Baird et al., 
1968). This situation can be further exacerbated by decreased feed intake and propionate 
supply. Additionally, accumulation of OAA as a result of the absence of hepatic PCK1 
activity can also dramatically inhibit the TCA cycle oxidation capacity and lead to fatty 
liver (Burgess et al., 2004, Beale et al., 2007).  
The two key enzymes that impact the OAA pool size are PC and PCK (Owen et 
al., 2002). An optimal expression ratio between these two enzymes may be critical for 





bovine has been demonstrated to be differentially regulated by fatty acids and during feed 
restriction (White et al., 2011a, b). Despite the extensive research on PCK1 in 
nonruminant animals, it is yet unknown how bovine PCK1 transcription is regulated by 
hormones and nutrients. Information about the nutritional and hormonal regulation of 
bovine PCK1 gene expression may facilitate developing guidelines for prevention and 
treatment of ketosis and fatty liver in dairy cows. 
Conclusions and future directions  
Phosphoenolpyruvate carboxykinase (PCK) catalyzes the conversion of OAA to 
PEP, a critical cataplerotic reaction that impacts gluconeogenesis, glyceroneogenesis, and 
TCA cycle capacity.  In nonruminants, expression of PCK1 is acutely regulated by 
hormones and nutrients at the transcriptional level, most notably through induction by 
glucagon and glucocorticoids, and insulin represses these effects.  A number of cis-DNA 
regulatory elements within the rat PCK1 promoter have been identified that allow for 
tissue-specific expression of PCK1 mRNA and the responsiveness to hormonal and 
nutritional cues.  In contrast, there is lack of data for regulation of bovine PCK1 promoter 
by hormone and nutrients, and data from nonruminants may not readily be applicable for 
ruminants regarding unique regulation of PCK1 expression by feed intake. In contrast to 
nonruminants in which PCK1 expression is induced by starvation, increased expression 
of PCK1 mRNA was observed during periods with increased feed intake, a condition 





We hypothesized that propionate may regulate its own metabolism through 
inducing PCK1 expression in liver of dairy cattle. Direct effects of propionate on hepatic 
PCK1 mRNA expression using both animal models and in vitro cell culture models are 
described in this dissertation.  The subsequent chapters describe the responsiveness of 
bovine PCK1 promoter to SCFA, including acetate, propionate and butyrate as well as 
hormonal cues including cAMP, dexamethasone and insulin.  
These data will provide critical information for regulation of PCK1 expression 
and activity and gluconeogenic capacity in liver of dairy cattle in response to altered 
propionate supply and hormonal status.  This new information will also be valuable for 
understanding the regulation of TCA cycle activity by a major rumen fermentation 
product, which is critical for complete oxidation of acetyl-CoA generated from fatty acid 
β-oxidation during periods of elevated mobilization of adipose tissue, such as early 
lactation in dairy cows. Guidelines can be developed from the fundamental information 
of this work and used to optimize production and health of dairy cows as well as prevent 
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CHAPTER 2. EFFECT OF PROPIONATE ON MESSENGER RNA EXPRESSION 
OF KEY GENES FOR GLUCONEOGENESIS IN LIVER OF DAIRY CATTLE 
Abstract 
The current study evaluated the effects of increasing propionate supply on mRNA 
expression of bovine cytosolic phosphoenolpyruvate carboxykinase (PCK1), 
mitochondrial phosphoenolpyruvate carboxykinase (PCK2), pyruvate carboxylase (PC) 
and glucose-6-phosphatase (G6PC), key enzymes for hepatic glucose production in liver 
of dairy cattle.  In experiment 1, six multiparous mid-lactation Holstein cows were 
utilized in a replicated 3×3 Latin Square design consisting of a 6-d acclimation or 
washout phase followed by 8-h of postruminal infusion of either propionate (1.68 mol), 
glucose (0.84 mol), or an equal volume (10 mL/min) of water.  In experiment 2, twelve 
male Holstein calves were given intravenous infusion of either propionate (2 mmolh-
1(BW.75)-1, acetate (3.5 mmolh-1(BW.75)-1, or an equal volume (4 mL/min) of saline.  In 
both experiments blood samples were collected at 0, 2, 4, 6, and 8-h relative to the start 
of infusion and liver biopsy samples were collected at the end of the infusion interval and 
subjected to mRNA analysis.  Liver explants from experiment 1 were used to measure 
tricarboxylic acid cycle flux and gluconeogenesis using 
13







C3 propionate.  Compared with water infusion, postruminal propionate 
infusion in mid-lactation cows elevated plasma propionic acid concentration (36.9 vs. 
59.0 µM) by the end of the 8-h infusion.  Serum insulin concentration was increased in 
response to propionate infusion by 1.94-fold compared to water infusion, but was not 
different between infusions of propionate and glucose.  Hepatic expression of PCK1 and 
G6PC mRNA and glucose production in cows receiving propionate were not different 
from cows receiving water infusion, but tended to be higher compared to cows receiving 
glucose infusion.  Expression of PCK2 and PC mRNA was not altered by propionate 
infusion in mid-lactation cows.  Blood glucose, insulin and glucagon in calves 
intravenously infused with propionate were not different than controls.  Calves receiving 
propionate infusion had increased PCK1 mRNA, tended to have increased G6PC mRNA, 
and had similar PC mRNA compared with saline controls.  These data indicate in vivo 
effects of propionate to alter hepatic gene expression in mid-lactation cows and neonatal 
calves.  The effects of propionate in mid-lactation cows are accompanied by a 
commensurate increase in serum insulin concentration; however, expression of PCK1 in 
liver appears to be refractory to the repressive effects of insulin with propionate infusion.  
These observations are consistent with a feed-forward effect of propionate to regulate its 
own metabolism towards gluconeogenesis through changes in PCK1 mRNA.    







Propionate is the primary precursor for glucose synthesis in dairy cows and 
contributes as much as 60-74% of the carbon for gluconeogenesis (Aschenbach et al., 
2010).  Hepatic glucose production is proportional to propionate supply in dairy cows 
(Baird et al., 1980), and glucose demand to support milk synthesis in the mammary gland 
increases dramatically at parturition.  The transition dairy cow is often challenged in 
meeting glucose needs due to inadequate feed intake (Bell, 1995).  Methods to increase 
propionate supply, as the supply of glucogenic precursors during this critical period 
include modifications to alter the diet, ruminal fermentation pattern, or to directly supply 
of glucogenic precursors (Duffield et al., 2002; Duffield et al., 2003; Overton and 
Waldron, 2004).  However, there is a lack of data for adaptations in liver of ruminants in 
response to changes in supply of gluconeogenic precursors, particularly propionate.   
The rate of gluconeogenesis in liver is controlled by activity of several flux-
controlling enzymes, including phosphoenolpyruvate carboxykinase (PCK), glucose-6-
phosphatase (G6PC) and pyruvate carboxylase (PC) that are responsive to hormonal and 
allosteric regulation (Pilkis et al., 1988; Pilkis and Granner, 1992; Aschenbach et al., 
2010).  There are two isoforms of PCK, cytosolic form (PCK1) and mitochondrial form 
(PCK2).  Expression of PCK1 and G6PC mRNA were induced by propionate in rat 
hepatocytes and H4IIE hepatoma cells (Massillon et al., 2003).  Although the role of 
propionate as a regulatory molecule may be questioned in nonruminants due to the low 
quantities reaching liver, there is growing evidence in ruminants to suggest that the 





feed intake and propionate supply.  Studies from our laboratory indicate that expression 
of PCK1 is elevated when feed intake is increased during early lactation (Greenfield et 
al., 2000; Agca et al., 2002) and with prepartum supplementation of monensin (Karcher 
et al., 2007), conditions linked to increased propionate production from the rumen.   
In neonatal calves, the onset of rumen development is marked by the production 
and absorption of short-chain fatty acids (SCFA) and hence, an increase in propionate 
concentration in hepatic portal blood.  The impact of propionate on gluconeogenic 
capacity in developing ruminants is equivocal.  The rate of gluconeogenesis from 
propionate is acutely responsive to changes in propionate concentration in hepatocytes 
from neonatal calves (Donkin and Armentano, 1994), but prolonged exposure of 
hepatocytes from preruminating calves to valerate had no effect on subsequent capacity 
for gluconeogenesis from propionate (Donkin and Armentano, 1993).  However, the 
effects of prolonged exposure to propionate on hepatic gene expression have not been 
determined, although rates of gluconeogenesis from propionate are similar between 
preruminant and ruminating calves despite a decrease in gluconeogenesis from lactate 
(Donkin and Armentano, 1995).  Data for sheep indicate induction of genes in adipose 
tissue in response to propionate infusion (Lee and Hossner, 2002).  Taken together, the 
data suggest a need for additional information on the role of propionate on expression of 
key genes for hepatic gluconeogenesis.  
We hypothesized that increasing propionate supply would promote expression of 
key genes for gluconeogenesis to enhance gluconeogenic capacity in neonatal calves and 
lactating cows.  The objectives of this study were to determine the effect of propionate on 





metabolically naive with regard to post-absorptive propionate supply, and to determine 
the effects of augmenting the supply of propionate in mid-lactation dairy cows.  The 
combined observations from these studies indicate that mRNA expression of PCK1 and 
G6PC is elevated in response to propionate supply in neonatal calves and is maintained in 
mid-lactation cows despite an increase in blood insulin concentrations.  
Materials and methods  
Experimental Design and Animal Management  
All experimental procedures involving animals were approved by the Purdue 
University Animal Care and Use Committee. 
Experiment 1.  Six early multiparous Holstein cows fitted with rumen cannula 
were selected from the Purdue Dairy Research and Education Center dairy herd and used 
in a replicated 3×3 Latin Square design.  Cows were 81±28 DIM, weighed 555±47 kg, 
had a BCS of 2.50 ± 0.25, with a milk production of 35 ± 13 kg/d at the initiation of the 
experiment.  Cows were housed in individual tie stalls and fed a TMR (Table 1) delivered 
once daily at 0600 h in an amount to achieve approximately 10% feed refusals over the 
following 24 h interval.  Ration ingredients were analyzed for DM once weekly and used 
to make adjustments to the as-fed proportions of the TMR.  Cows had free access to feed 
and water except for 20 minutes twice daily when they were moved to the milking parlor.  
Feed intake was measured daily by difference for each cow from the quantities of feed 





chemical composition using wet chemistry methods (Dairy One, Ithaca, NY).  Dry matter 
intake was calculated using the DM content of the TMR offered.  Cows were milked 
twice daily, and individual milk yields were determined electronically at each milking 
(Herd Master Galaxy Management, Alfa-Laval Agri Inc., St. Louis, MO).  
The experiment was 21-d in duration and consisted of three 7-d periods.  Each 
period consisted of a 6-d washout phase when cows were fed a TMR for ad libitum feed 
intake and an 8-h infusion phase when cows received postruminal infusion of glucose, 
propionate, or water.  On day 7 of each period, cows were fitted with indwelling jugular 
catheters for blood sampling and infusion lines that extended through the rumen cannula 
to the abomasum as previously described (Gressley et al., 2006).  Baseline (0 h) blood 
samples were collected for each cow and postruminal infusions were initiated and 
administered for the subsequent 8-h period using a peristaltic pump.  Treatment solutions 
were prepared by dissolving 160.4 g (1.68 mol) of sodium propionate or 150.4 g (0.84 
mol) of glucose respectively in 4.8 L deionized water.  Concentrations of propionate 
solution and glucose solution were 0.35 mol/L and 0.175 mol/L, respectively, and 4.8 L 
of each solution or water were delivered into the abomasum at a constant rate of 10 
mL/min over the 8-h period.  The quantities of propionate and glucose infused were 
designed to be isoenergetic.  Cows were fed their daily TMR at the beginning of the 
infusion period and DMI was determined over the subsequent 8-h and 24-h periods.   
Experiment 2.  Twelve male Holstein calves were blocked by birth date and 
assigned to receive, at 7 days of age, either propionate infusion, acetate infusion or saline 
infusion. 
 
Calves were fed colostrum at birth and for the first 48 h of life and then 





day of infusion, calves were fitted with indwelling catheters in the right and left jugular 
veins between 0600 and 0700.  One catheter was used for infusion and the other was 
maintained for sampling blood sampling.  Calves received jugular infusions of either 
propionate at 2 mmolh-1(BW.75)-1, acetate at 3.5 mmolh-1(BW.75)-1 or saline at 4 
mL/min over an 8-h period using a peristaltic pump.  The quantities of acetate and 
propionate infused were designed to be isoenergetic and the volume for all infusates 
delivered over the 8-h period was 1.9 L.    
Sample Collection and Analysis 
For experiments 1 and 2, blood samples were collected from indwelling jugular 
catheters and transferred to evacuated tubes (Becton Dickinson, Rutherford, NJ).  
Samples were collected just prior to infusion and at 2, 4, 6, and 8 h relative to the start of 
infusion.  Collection tubes for plasma glucose analysis contained sodium fluoride and 
potassium oxalate.  Tubes for plasma SCFA analysis contained lithium heparin.  Tubes 
for plasma glucagon analysis contained K2-EDTA.  Serum separator tube was used for 
serum collection.  Tubes for plasma preparation were put on ice immediately after 
sampling, then centrifuged at 4 ºC at 3,000× g for 20 min.  Tubes for serum preparation 
were allowed to clot for 30 min at room temperature before centrifugation for 15 min at 
1000 × g.  Plasma and serum were stored at -20 ºC until analysis.  Plasma for glucagon 
analysis was aliquoted into two borosilicate glass culture tubes containing 500 KIU of 
aprotinin per ml of plasma and frozen at -20 ºC pending analysis.  For experiment 2, 





infusion.  On the rare occasion that blood could not be drawn using catheters, blood 
samples were collected by jugular venipuncture for calves and coccygeal vein or artery 
for cows. 
Plasma was analyzed for glucose (Wako Chemicals USA, Inc., Richmond, VA).  
Serum insulin was quantified by a solid-phase 
125
I radioimmunoassay kit (Coat-A-Count 
Insulin, Siemens Medical Solutions USA, Inc., Malvern, PA).  The intra-assay and inter-
assay CV for insulin was 1.9% and 4.8% respectively.  Glucagon was quantified by a 
125
I 
radioimmunoassay kit (Double Antibody Glucagon, Siemens Medical Solutions USA, 
Inc., Malvern, PA) with an intra- and inter-assay CV of 8.7% and 4.4% respectively.  
Plasma propionate, acetate and butyrate were quantified by using Liquid 
Chromatography-Mass Spectrometry (LC/MS) based on Group Specific Internal 
Standard Technology labeling method (Jannasch et al., 2011) at the Bindley Bioscience 
Center (Purdue University Discovery Park).  For sample and standard derivatization, 100 
uL of plasma or standard mixture (containing 100 ng/uL of propionic acid, acetic acid 
and butyric acid) was mixed with 10 uL of  freshly made N-(3-dimethylaminopropyl)-N′- 
ethylcarbodiimide hydrochloride (EDC, 200 mg/mL; Sigma-Aldrich, St. Louis, MO) and 
10 uL of  6 M aniline (pH=4.5).  The aniline mixed with the sample was unlabeled (light) 
while the aniline mixed with the standard solution was 
13
C6-aniline (heavy).  After 2-h 
incubation, 5uL of triethylamine (TEA, Ph = 8.0, Sigma-Aldrich, St. Louis, MO) was 
added to stop the reactions; 20 uL of the derivatized sample and 20 uL of the derivatized 
standards mixture were mixed and quantified using LC/MS (6460 Triple Quadrupole 





individual short-chain fatty acids was calculated from the measured isotope ratios 
(light/heavy) as described by Jannasch et al. (2011).   
Liver biopsy samples (500 to 1000 mg) were obtained by percutaneous needle 
biopsy at the end of 8-h infusion of each period in experiment 1, and at the end of the 8-h 
infusion in experiment 2 as previously described (Hammon et al., 2003).  One aliquot of 
liver sample was rinsed in saline and transferred to plastic vials containing Trizol reagent 
(Life Technologies corp., Carlsbad, CA), frozen in liquid nitrogen and stored in -80 ºC 
pending mRNA extraction and analysis.  For experiment 1, a second aliquot of liver was 
placed in Dulbecco’s Modified Eagle’s medium (DMEM), supplemented with 1% bovine 
serum albumin (BSA), transported back to the lab within 15 min, and used for 
13
C-
metabolite flux analysis.  
Total RNA was isolated using Trizol reagent, and 50 µg of the resulting RNA was 
further purified using RNeasy Mini Kit (Qiagen, Inc., Thousand Oaks, CA).  A total of 2 
µg of purified sample was reverse transcribed to cDNA using an Omniscript reverse 
transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random decamers (Ambion, Foster 
City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA).  Abundance of cDNA for 
each sample was quantified using real-time PCR, Brilliant Ⅲ Ultra-Fast SYBR Green 
QPCR Master Mix (Agilent Technologies, Inc., Santa Clara, CA) with primers described 
below.  A cDNA pool was generated from an equivalent quantity of cDNA from each 
sample.  A 1:4 dilution series of the cDNA pool was used to generate the standard curve.  
No template control (using water as a template) and no reverse transcription control 
(using RNA pool as a template) were included in the real-time PCR analysis.  The 






bovine PCK2, TGACTGGGCAAGGGGAGCCG, GGGGCCACCCCAAAGAAGCC; 
bovine PC, CCACGAGT TCTCCAACACCT, TTCTCCTCCAGCTCCTCGTA; bovine 
G6PC, TGATGGACCAAGAAAGATCCAGGC, 
TATGGATTGACCTCACTGGCCCTCTT; bovine 18S, 
ACCCATTCGAACGTCTGCCCTATT, TCCTTGGATGTGGTAGCCGTTTCT.  
Reactions were as follows: 1 cycle at 95 °C for 3 min; 40 cycles at 95 °C for 10 s, 60 °C 
for 20 s; 1 cycle at 95 °C for 1 min, 55 °C for 30 s, and 95 °C for 30 s.  Samples were 
analyzed in triplicate and PCR reaction efficiencies were between 90% and 110%.  Mean 
values for transcripts evaluated were normalized to mRNA abundance of 18S within each 




C-metabolite flux analysis, liver explants (3-4 mm thick and 9 mm in 
diameter) were prepared using a razor blade, placed in 20 ml glass scintillation vials 
(Research Products International Corp., Mount Prospect, IL), gassed with 95% O2:5% 
CO2, and incubated at 37 ºC for 2 h in glucose-free DMEM supplemented with 1% BSA, 
2.5 mM sodium propionate (49.5% atom percent excess of [
13
C3] propionate), and 1 mM 
sodium lactate.  Incubations were terminated by placing on ice; the liver explant was 
removed, weighed and frozen at -80 ºC, then shipped on dry ice to the University of 
Maryland and processed for the 
13
C-mass isotopomer distribution analysis of metabolites.  
Briefly, liver tissue was homogenized in 1 mL of sulfosalicylic acid (50%, wt/vol) and 
centrifuged at 10,000 x g at 4°C for 20 min.  The acid-supernatant was desalted by cation 





with 2 M NH4OH followed by water and lyophilized to dryness.  The amino acids were 
converted to their tert-butyl dimethylsilyl derivatives (Calder et al., 1999) before loaded 
onto GC–MS (HP 5973N Mass Selective Detector, Agilent, PaloAlto, CA).  The MS was 
set to monitor selected ions of m/z (alanine 321 to 324, aspartate 421 to 425, glutamate 
435 to 440, and serine 533 to 536) under methane negative chemical ionization 
conditions. The normalized crude ion abundances of the enriched analytes were corrected 
for the natural abundance of stable isotopes present in the original molecule and that 
contributed by the derivative using the matrix approach (Fernandez et al., 1996). 
The 
13
C-isotopomer enrichments were expressed as tracer: trace ratios (TTR), 
which was mol 
13
C- isotopomer [M + n] per 100 mol 
12
C-isotopomer [M + 0], where n 
equals the number of 
13
C- labeled carbons in the analyte.  The fractional contribution of 
precursor to product was calculated as the ratio of TTRproduct to TTRprecursor (El-Kadi 
et al., 2009).  Entry of [1, 2, 3-
13
C] propionate to the tricarboxylic acid cycle (TCA) cycle 
introduces [1, 2, 3-
13
C] oxaloacetate (OAA) containing 
13
C in carbons 1, 2, and 3 in the 
first pass.  The [1, 2, 3-
13
C] OAA will subsequently randomize to [2, 3, 4-
l3
C] OAA due 
to the reversible reactions of malate dehydrogenase and fumarase.  These two [M + 3] 
OAA isotopomers are unique products of propionate carboxylation, and will achieve a 
metabolic equilibrium with their transamination partner [M + 3] aspartate isotopomers.  
Thus, the proportion of OAA flux derived from metabolism of propionate was calculated 
as the mole ratio of [M + 3] aspartate to [M + 3] propionate.  Oxaloacetate is either 
metabolized as an intermediate through the TCA cycle or converted to PEP via PCK.  For 
metabolism in the TCA cycle, OAA and acetyl-CoA form citrate. Citrate is 





transamination partner, glutamate.  The transformation of positional isotopomers of OAA 
through the TCA has been extensively demonstrated by Lee (1993).  Briefly, all 
13
C- 
isotopomer [M + n] of glutamate is originated from [M + 3] propionate via the TCA 
cycle.  Therefore, the TCA cycle flux from propionate was expressed as the percentage of 
total 
13
C in glutamate relative to the total 
13
C in propionate.  In addition, via PCK, [1, 2, 
3-
13
C] OAA is converted to [M + 3] PEP, and [2, 3, 4-
13
C] OAA loses one 
13
C and forms 
[M + 2] PEP.  The [M + 3] PEP can be recycled via pyruvate kinase to [M + 3] pyruvate 
which can be quantitated as analog [M + 3] alanine.  Taken together, the flux from OAA 
to pyruvate via PCK was determined from the ratio of [M + 3] alanine to ½ [M + 3] 
aspartate.  Otherwise, because [M + 3] PEP can be used to synthesize [M + 3] 3-
phosphoglycerate, which is eventually utilized for gluconeogenesis and because [M + 3] 
3-phosphoglycerate is in equilibrium with its analog [M + 3] serine, flux from OAA to 
glucose via PCK was estimated by the ratio of [M + 3] serine to ½ [M + 3] aspartate.   
Statistical Analyses 
Data were analyzed for normality using UNIVARIATE procedure of SAS 9.2, 
and any heteroscedastic data were transformed to achieve normality using a natural 
logarithm transformation.  Analyses of variance of the data were performed using the 
Proc Mixed procedure of SAS.  Experiment 1 was analyzed as a replicated 3 x 3 Latin 
square.  The basic model accounted for the fixed effects of square, period, treatment, and 
random effects of cow within square.  In experiment 2, the basic model accounted for the 





measures in both experiments, the effect of time relative to start of infusion and the 
interaction of time by treatment were added to the basic models with time as repeated 
measures.  For the repeated statement, the covariance structure autoregressive (1) yielded 
the lowest Akaike information criteria (AIC), and was used in the final models.  In 
addition, preplanned comparisons of paired treatments were made using Dunnett’s test.  
The comparisons included propionate vs. water and propionate vs. glucose in experiment 
1; propionate vs. saline and propionate vs. acetate in experiment 2.  Data are reported as 
least square means ± SEM.  Means were considered different when P < 0.05, and tended 
to differ when 0.05 ≤ P ≤ 0.10.  
Results 
Experiment 1 
DMI and Milk Production.  Propionate infusion did not alter DMI during the 8-h 
and 24-h periods relative to the start of infusion (Table 2).  Milk yield on the day of 
infusion was not different among treatments (Table 2).  
mRNA Analysis.  There was a tendency (P = 0.10) for an overall effect of 
infusions on PCK1 mRNA abundance, and no overall treatment effects for PCK2, PC and 
G6PC mRNA abundance (Table 2).  Preplanned comparisons revealed a tendency for 
increased PCK1 mRNA (P = 0.09) and G6PC mRNA (P = 0.10) with propionate infusion 





Plasma and Serum Metabolites and Hormones.  There was a tendency (P = 
0.07) for an overall effect of infusions on plasma propionic acid concentrations at 8-h 
relative to start of infusion, and no differences in concentrations of acetic acid and butyric 
acid (Table 2). Preplanned comparisons indicated elevated (P = 0.045) propionic acid 
concentration and a tendency (P = 0.09) for reduced acetic acid concentration at 8-h 
relative to start of infusion with propionate infusion compared to water infusion.  
No differences were detected for concentrations of plasma glucose and glucagon, 
except a time effect (P = 0.02) for plasma glucagon concentration (Table 2).  Due to the 
differences (P = 0.047) for preinfusion (0 h) insulin concentration among treatment 
groups, fractional changes in insulin concentrations relative to the initial concentrations at 
0-h were used to determine the effect of treatments on insulin (Table 2).  There was a 
main effect (P = 0.02) of treatments on serum insulin, and propionate elevated (P = 0.01) 
serum insulin concentrations compared to water infusion (Table 2; Figure 2.1).  Time 
effect (P = 0.008) and treatment by time interaction (P = 0.03) on insulin concentration 
were also observed (Table 2; Figure 2.1). 
13
C-Metabolite Flux Analysis. The 
13
C-Metabolite distribution analysis was used 
to demonstrate the effects of infusions on intracellular metabolic flux and glucose 
production in liver explants.  There were no differences in formation of OAA from 
propionate, and the contribution of TCA flux from propionate among treatments (Figure 
2.2).  However, there was a significant overall treatment effect (P = 0.01) and tendency 
(P = 0.10) for formation of pyruvate from OAA via PCK, and production of glucose from 
OAA via PCK respectively (Figure 2.2).  Consistent with the gene expression data, 





0.10) the flux from OAA to pyruvate via PCK and the contribution of OAA to glucose 
production via PCK by 30% and 60% respectively compared to glucose infusion (Figure 
2.2).  
Experiment 2 
mRNA Analysis.  There was an overall effect (P = 0.008) of infusions on PCK1 
mRNA abundance (Table 3).  Compared to saline infusion, propionate infusion 
significantly increased (P = 0.005) PCK1 mRNA expression (Table 3).  Likewise, the 
abundance of G6PC mRNA was different (P = 0.04) among treatments, and there was a 
tendency (P = 0.08) for increased G6PC mRNA in response to propionate compared to 
saline infusion (Table 3). Expression of PC mRNA was not different among treatments 
(Table 3).  
Plasma and Serum Metabolites and Hormones.  Blood concentrations of glucose, 
glucagon and insulin were not different among treatments, except a time effect (P < 0.01) 
and a tendency (0.05 ≤ P ≤ 0.10) for time by treatment interaction on blood glucagon and 
insulin concentrations (Table 3).  
Discussion 
 Previous studies indicated that hepatic PCK1 mRNA expression in dairy cows 
was increased when DMI was increased during early lactation (Greenfield et al., 2000; 





The fact that both of these conditions likely increase ruminal propionate supply suggests 
a possible role of propionate in regulating the expression of PCK1 mRNA in liver.  In 
this study, we have demonstrated that hepatic PCK1 mRNA expression is positively 
regulated in response to increased supply of propionate in mid-lactation cows and 
neonatal calves.  The increased PCK1 mRNA expression was accompanied with higher 
glucose production in liver of mid-lactation cows.  We used mid-lactation cows in order 
to determine the impact of propionate supply on hepatic gene expression in animals that 
were in positive energy balance and not challenged with regard to glucose needs.  
Neonatal calves were used to assess the impact of short-term changes in propionate 
supply in animals that were naive with regard to the supply for propionate to liver from 
rumen fermentation.   
 Experiments reported here utilized an isoenergetic infusion of glucose or acetate 
to match the glucogenic potential of propionate, and an equal volume of water or saline to 
control for the effects of the infusion protocol.  The postruminal infusion technique used 
for experiment 1 supplied additional propionate or glucose directly to the abomasum and 
avoided disrupting rumen fermentation.  The level of propionate selected for experiment 
1, 0.21mol/h, augmented propionate supply by approximately 25% based on net flux of 
propionate across portal drained visceral in dairy cows (Reynolds et al., 1988) and an 
assumed absorption rate of 100%.  This  increase in propionate supply was intended to 
match the increases in ruminal propionate production estimated with  monensin 
supplementation given that the addition of 420 mg/d monensin increased the molar 
percentage of propionate produced in the rumen from 25% to 30% without altering feed 





propionate of 0.79 mol/h without monensin (Reynolds et al., 1988), this value is 
estimated at 0.95 mol/h with addition of monensin in the diet of early lactation dairy 
cows, resulting in approximately 20% increase in net flux of propionate across portal 
drained visceral, and similar to the level of propionate supplied in our study.    
Previous studies have documented a depression in DMI in response to increased 
propionate supply in early lactation and mid-lactation cows (Oba and Allen, 2003a, Oba 
and Allen, 2003b; Stocks and Allen, 2014), thus pointing to propionate as a potential 
intake satiety signal (Allen et al., 2009).  Stimulation of oxidative metabolism in the liver 
by propionate has been proposed as a cause of this intake induced hypophagia in dairy 
cattle (Allen et al., 2009).  However, the extent of hypophagia in response to propionate 
appears to vary with physiological state and the level of propionate supplied.  Feed intake 
in early lactation cows, but not mid-lactation cows was depressed by 18-h ruminal 
infusion of propionate at a rate of 0.78 mol/h (Oba and Allen, 2003a). The threshold for 
the hypophagic effect of propionate, during 18-h ruminal infusion, was not achieved until 
the infusion concentration reached 0.83 mol/h in early lactation cows (Oba and Allen, 
2003c). This amount is equivalent to the net portal appearance of propionate (0.79 mol/h) 
in early lactating dairy cows fed a typical lactation diet (Reynolds et al., 1988).  
Therefore, a doubling the hepatic propionate flux is needed to acutely affect feed intake, 
and the lack of depression in DMI with propionate infusion in the present study is not 
surprising.  An increase in plasma glucose concentrations with propionate infusion below 
the hypophagic threshold (Oba and Allen, 2003c) may suggest that propionate was 
mainly used for gluconeogenesis instead of oxidation under those conditions.  Our data 





PCK1 mRNA to potentiate increased glucose production by liver.  The lack of difference 
in DMI in the present study supports a similar supply of propionate from the rumen for 
all treatment groups and eliminates any possible confounding effects of feed intake on 
hepatic gene expression. 
In ruminants, over 90% of propionate absorbed into portal blood is removed by 
liver in the first pass, and approximately 90% is used for glucose production (Lomax and 
Baird, 1983; Reynolds et al., 1988; Armentano, 1992).  It has been proposed that entry of 
propionate into gluconeogenesis is mainly regulated via the enzyme activity of PCK1 
(Aschenbach et al., 2010).  The abundance of PCK1 mRNA and the activity of its 
enzyme product are directly proportional and are regulated at the transcriptional level of 
the PCK1 gene (Forest et al., 1997; Hanson and Reshef, 1997).  In contrast to our original 
hypothesis, postruminal infusion of propionate to mid-lactation cows did not increase 
PCK1 mRNA expression compared to water control.  The underlying reason may be the 
elevated blood insulin concentration in response to propionate infusion.  These data are 
consistent with previous studies that also observed an increase in circulating insulin with 
propionate infusion to cattle (Baird et al., 1980; Bines and Hart, 1984; Oba and Allen, 
2003a) and sheep (Brockman, 1990).  Insulin is known to potently and rapidly repress 
PCK1 transcription and hepatic PCK1 mRNA expression (Granner et al., 1983; Sasaki et 
al., 1984; Chakravarty and Hanson, 2007).  Consequently, repression of PCK1 mRNA 
and reduced gluconeogenic capacity would be an anticipated outcome of increased 
propionate supply, but clearly this is not the case in vivo as the increased propionate 
supply is linked to increased hepatic glucose output both in the present study and a 





expression of PCK1 is maintained in bovine liver by the action of propionate despite 
almost 2 times greater serum insulin concentrations.  This novel finding is consistent with 
generalized observations that hepatic capacity for gluconeogenesis from propionate in 
cattle is resistant to changes in blood insulin concentrations (Huntington et al., 2006), and 
a lack of specific change in rate of utilization of propionate for glucose production 
despite increased blood insulin in sheep (Brockman, 1990).  Our data have uniquely 
demonstrated that a counteracting effect of propionate on PCK1 mRNA expression is one 
underlying reason for these observations.   
The fact that propionate maintained PCK1 mRNA expression and hepatic 
gluconeogenesis from propionate in the face of elevated insulin is also supported by the 
observation that cows given postruminal infusion of glucose had similar blood insulin 
concentration to cows given propionate infusion, but displayed a 50% lower expression 
of PCK1 mRNA and similar reduction in glucose flux from OAA in liver explants 
cultures (Figure 2.3).  A similar flux coefficient for OAA formation from propionate and 
lack of difference for TCA cycle flux between cows given glucose or propionate suggests 
a lack of regulation of metabolism prior to the OAA pool for these groups of cows 
(Figure 2.3).  Interestingly, greater amount of OAA is converted to PEP in cows 
receiving propionate, leading to greater flux of pyruvate from OAA and, most 
importantly, greater flux of OAA to glucose in cows receiving propionate infusion 
(Figure 2.3).  Although our experiments do not distinguish between flux of OAA to PEP 
through cytosolic or mitochondrial pathways, the lack of change in PCK2 mRNA and 






 Synthesis of phosphoenolpyruvate from OAA directly in the mitochondrion via 
PCK2 balances the NADH produced during the oxidation of lactate to pyruvate in the 
cytosol (Croniger et al., 2002; Yang et al., 2009).  In ruminants, however, 
gluconeogenesis from propionate is not likely to be limited by cytosolic NADH (Aiello 
and Armentano, 1987).  Approximately 60% of propionate flux to glucose depends on the 
enzyme PCK2 in goat hepatocytes (Aiello and Armentano, 1987).  The lack of change in 
PCK2 mRNA with propionate infusion in mid-lactation cows is consistent with previous 
reports that the expression of PCK2 is not acutely controlled by hormones or metabolic 
changes in mammals (Girard et al., 1992; Hanson and Reshef, 1997; Croniger et al., 
2002).  In fact, unlike PCK1, the activity and turnover rate of PCK2 mRNA appear to be 
constitutive (Hanson and Reshef, 1997).  In ruminants, the activity and mRNA 
expression of PCK2 lack responsiveness to development, different hormonal status 
(Narkewicz et al., 1993), feed restriction (Velez and Donkin, 2005), and transition to 
lactation (Agca et al., 2002).  However, the present data indicate specific responsiveness 
of PCK1 to increased propionate supply.  
 Effects of propionate infusion in neonatal calves indicate expression of PCK1 and 
G6PC were increased in the absence of changes in blood insulin concentration.  Glucose-
6-phosphatase is the key enzyme that catalyzed the last step of gluconeogenesis and 
glycogenolysis to release glucose (Nordlie and Foster, 2010).  It is noteworthy that cattle 
liver lacks glucokinase, the enzyme that opposes G6PC in determining the abundance of 
glucose-6-phosphatate in liver cells (Raggi et al., 1963).  Taken together, elevated mRNA 
expression of PCK1 and G6PC in calves with propionate infusion and sustained levels of 





support a role for propionate acting through regulation of gene expression to control 
hepatic glucose metabolism.  Similar effects of propionate to induce PCK1 and G6PC 
mRNA expression were observed in primary cultures of rat hepatocytes where the 
principal response to propionate for G6PC mRNA is linked to activity of hepatic nuclear 
factor 4α (HNF-4α) on the G6PC gene promoter (Massillon et al., 2003).  In contrast to 
PCK1, the expression of PC mRNA, which encodes a critical enzyme for 
gluconeogenesis from lactate, was neither changed by propionate infusion in neonatal 
calves nor altered by infusions in mid-lactation cows.  This observation is consistent with 
previous studies where mRNA expression for PCK1, but not PC is altered in response to 
conditions that accompany increased ruminal propionate supply (Greenfield et al., 2000; 
Agca et al., 2002; Karcher et al., 2007).  The current data indicate regulation of bovine 
PCK1 mRNA by propionate in vivo.  Detailed analysis of the bovine PCK1 promoter and 
the relationship with signaling molecules including HNF-4α is necessary to more fully 







 Our data demonstrate that mRNA for PCK1 and G6PC, key gluconeogenic 
enzymes, are induced in response to increased propionate supply in dairy cattle.  This 
creates a ‘propionate paradox’ in dairy cattle where the capacity for gluconeogenesis is 
maintained despite elevated insulin levels due to the overriding action of propionate on 
the PCK1 gene.  When insulin is not elevated, as observed in neonatal calves, the 
capacity for gluconeogenesis is likely enhanced.  Overall, the data suggest propionate 
control of gluconeogenesis that is mediated at the molecular level through hepatic 
expression of PCK1, a key flux-regulating enzyme for gluconeogenesis.  Furthermore, 
the data indicate a feed-forward mechanism that links a primary SCFA produced in the 
rumen with its own metabolic fate, and infers an integration of hepatic metabolism in 
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Rations used in the two squares of experiment conducted in March and July respectively.  
2
Purchased from Church & Dwight Co., Inc., Princeton, N.J. 
3
Purchased from Venture Milling, Salisbury, Maryland. Ingredients contained 60% 
SoyPlus VM Nov and 40% LysAAmet. 
 4
Contained 55.4% Ground Corn Grain, 3.125 % Urea, 10% Calcium Carbonate, 6.25% 
Dicalcium Phosphate, 8.125% Sodium Bicarbonate, 2.5% Magnesium Oxide, 5% NaCl, 
2.5% Calcium Sulfate, 3.25% Yeast Culture (Diamond V Mills, Cedar Rapids, IA), 
0.35% Niacinamide (99% Niacin), 0.275% Vitamin E 20,000 IU/lb, 0.075% Rumensin 
90, 1.65% Omnigen AF (Prince-Agri Products, Quincy, IL), and 1.5% 5390 GS/PU 
Dairy.  
5







Table 2.2. Effects of postruminal propionate infusion on DMI, milk yield, blood concentrations of short-chain fatty acids, 
glucose and hormones and hepatic mRNA expression in mid-lactation dairy cows
1
 





  Main effects and interaction  Preplanned comparisons 
Item Water Glucose Propionate SEM Trt Time Trt x Time 






6.0 6.9    6.5 0.8 0.69 - -  0.85 0.89 
DMI, kg/d 19.4 21.4 20.2 1.2 0.17 - -  0.63 0.38 
Milk yield, kg/d 36.3 36.6 35.7 2.5 0.73 - -  0.81 0.66 
Propionic acid, µM 36.9 44.1 59.0 7.6 0.07 - -  0.045 0.21 
Acetic acid, µM 1295 1211 994 127 0.12 - -  0.09 0.23 
Butyric acid, µM 27.4 32.8 28.8 6.0 0.76 - -  0.98 0.82 
Glucose, mg/dL 62.7 63.2 63.1 1.2 0.91 0.22 0.46  0.93 0.99 









0.82 0.047 - -  0.03 0.20 
Δ insulin5 1.00 1.54 1.94 0.23 0.02 0.008 0.03  0.01 0.45 
PCK1 mRNA, AU
6
 1.33 0.65 1.45 0.29 0.10 - -  0.96 0.09 
PCK2 mRNA, AU
6
 1.11 0.78 1.20 0.23 0.24 - -  0.94 0.20 
PC mRNA, AU
6
 1.09 0.87 1.21 0.21 0.19 - -  0.72 0.14 
G6PC mRNA, AU
6
 1.05 0.71 1.31 0.19 0.15 - -  0.65 0.10 
1








Propionate = 1.68 mol of propionate infused into abomasum during 8 h; Glucose = 0.84 mol of glucose infused into 
abomasum during 8 h; Water = equivalent volume of water into abomasum during 8 h.  
3





serum insulin concentrations at 0-h relative to start of infusion.    
5
Fractional changes in serum insulin concentrations relative to the initial concentrations at 0 h.    
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Table 2. 3. Effects of intravenous propionate infusion on blood concentrations of glucose and hormones and hepatic mRNA 
expression in neonatal calves
1
 




  Main effects and interaction  Preplanned comparisons 









111.9 117.1 102.5 4.9 0.16 0.80 0.36  0.34 0.11 
Glucagon, pg/mL 52.2 52.1 51.6 10.9 1.00 0.004 0.07  1.00 1.00 
Insulin, µIU/mL
 









0.27 0.008 - -  0.005 0.37 
PC, mRNA AU
4









0.45 0.04 - -  0.08 0.79 
1
Data are presented as least square means with SEM. 
2
Propionate = Intravenous infusion of propionate at 2 mmol/h/kg BW
. 75
 during 8 h; Acetate = intravenous infusion of acetate 
at 3.5 mmol/h/kg BW
. 75
 during 8 h; Saline = intravenous infusion of saline at 4 ml/min during 8 h.  
3
Probabilities corresponding to the main effects of treatment and time, interaction of treatment by time, and preplanned 
comparisons. 
4








Figure 2. 1. Effect of postruminal propionate infusion on fractional changes in serum 
insulin concentrations in mid-lactation dairy cows. Propionate (1.68 mol), glucose (0.84 
mol) or equivalent volume of water was infused into the abomasum over an 8-h interval 
in a replicated 3 × 3 Latin Square design.  Blood samples were collected every 2 h, and 
fractional changes in serum insulin concentrations were calculated relative to the initial 
concentrations at 0 h.  Data are least square means ± SEM for each treatment at each time 
point.  There were effects of treatment, time and treatment by time interaction (P < 0.05).  
Propionate infusion increased serum insulin concentrations compared to water infusion 
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Figure 2. 2. Effects of postruminal propionate infusion on 
[13C]
 metabolite flux in liver 
explants. Propionate (1.68 mol), glucose (0.84 mol) or equivalent volume of water was 
infused into the abomasum of mid-lactation dairy cows over 8 h during each period of a 
replicated 3 × 3 Latin Square design.  Liver explants cultures were used to measure (A) 
oxaloacetate formation from propionate, (B) Tricarboxylic Acid Cycle (TCA) cycle flux 
from propionate, (C) pyruvate formation from oxaloacetate via PCK, and (D) glucose 
production from oxaloacetate via PCK.  An asterisk (*) indicates a tendency for 

























































































































































 The intermediates used for estimate the relative metabolic fluxes are marked with boxes.  
The relative flux from propionate to oxaloacetate (OAA) and the tricarboxylic acid 
(TCA) cycle flux from propionate were not different for the two infusion groups.  The 
metabolic flux from OAA to phosphoenolpyruvate (PEP) via PCK is increased as 
indicated by the increased pyruvate formation from OAA via PCK and gluconeogenic 
flux from OAA via PCK.  Abbreviations: KG, ketoglutarate; G3P, Glyceraldehyde-3-
phosphate; PCK, phosphoenolpyruvate carboxykinase; PCK1, cytosolic 
phosphoenolpyruvate carboxykinase; PCK2, mitochondrial phosphoenolpyruvate 
carboxykinase; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase. 
 
 
Figure 2. 3. Overview of propionate metabolism to glucose and flux relationships among key 





CHAPTER 3. PROPIONATE INDUCES MESSENGER RNA EXPRESSION OF 
GLUCONEOGENIC GENES IN BOVINE CALF HEPATOCYTES 
Abstract 
Hepatocytes monolayers from neonatal calves were used to primarily determine 
the responses of the cytosolic phosphoenolpyruvate carboxykinase (PCK1) mRNA 
expression to propionate and hormonal cues including cyclic AMP (cAMP), 
dexamethasone and insulin.  Expression of PCK1 mRNA was 0.85, 0.89, 0.92, 1.30 and 
0.88 ± 0.11 for 0, 0.625, 1.25, 2.5 and 5 mM propionate for 6 h respectively.  An increase 
in PCK1 mRNA was observed with 2.5 mM propionate, but concentrations of 0.625, 1.25 
and 5.0 mM were without effect on PCK1 mRNA abundance.  Exposure to 2.5 mM 
propionate increased PCK1 mRNA at 3 h and 6 h of incubation, but the induction 
dissipated by 12 h.  The direct induction of PCK1 mRNA by propionate was similar to 
the effect of 1 mM cAMP and combination of 1 mM cAMP and 5 µM dexamethasone.  
The induction of PCK1 mRNA by propionate, cAMP, or the combination of cAMP and 
dexamethasone was eliminated by addition of 100 nM insulin.  Response of other key 
gluconeogenic genes including mitochondrial phosphoenolpyruvate carboxykinase 
(PCK2), pyruvate carboxylase (PC), and glucose-6-phosphotase (G6PC) to propionate 





dose dependent increase in PC mRNA as well as lack of response in G6PC mRNA.  
These findings demonstrate that propionate can directly regulate its own metabolism in 
bovine calf hepatocytes through up-regulation of PCK1, PCK2 and PC mRNA 
expression.   






The importance of gluconeogenesis in ruminants is highlighted by the extensive 
fermentation of dietary soluble sugars and starch in the rumen despite metabolic needs 
for glucose by tissues especially as a precursor for lactose synthesis (Aschenbach et al., 
2010).  Hypoglycemia, ketosis, and related metabolic disorders are often observed when 
gluconeogenic capacity in liver fails to adapt to the increased tissue demands for glucose 
metabolism in dairy cattle.  The prevalence of this insufficiency is highlighted by reports 
that the incidence of ketosis in commercial dairy herds may be as high as 17% (Dohoo 
and Martin, 1984).  Because propionate contributes approximately 50% of the carbon for 
gluconeogenesis (Huntington, 1990), strategies to increase propionate supply, including 
monensin feeding, have successfully reduced the incidence of ketosis in transition dairy 
cows (Duffield et al., 1998).  In addition to the documented impact of monensin on feed 
efficiency and increased ruminal propionate production (Sauer et al., 1989), a portion of 
the effect of monensin in transition cows may be linked to increased capacity for 
gluconeogenesis through enhanced expression of cytosolic phosphoenolpyruvate 
carboxykinase (PCK1) (Karcher et al., 2007), a key gene for glucose synthesis. 
Control of PCK1 enzyme activity has been studied extensively in nonruminants 
and is primarily exerted through transcription of the PCK1 gene via activation of basal, 
tissue-specific, and hormone-dependent promoter elements within the 5'-flanking region 
of the gene (Hanson and Reshef, 1997).  Expression of PCK1 mRNA in nonruminants is 
activated by glucagon and glucocorticoids and insulin counteracts these effects (O'Brien 





and Donkin, 2005) and sheep (Filsell et al., 1969, Taylor et al., 1971, Smith et al., 1982) 
is in direct contrast with data from nonruminants demonstrating that feed restriction 
induces the PCK1 gene (Hanson and Reshef, 1997).  Although in vivo administration of 
glucagon in dairy cattle suggests PCK1 induction in dairy cattle (Bobe et al., 2009).  
These data are equivocal perhaps due to counterregulatory release of insulin and other 
hormones (Bobe et al., 2009) in the experimental models used.   
Regulation of PCK1 in response to glucagon and other hormones has been 
extensively studied in rat hepatocytes and hepatoma cells.  The mRNA for PCK1 is 
maximally induced by cyclic AMP (cAMP) in presence of glucocorticoids within 3 h 
(Christ et al., 1988).  Likewise, short-chain fatty acids (SCFA), including propionate, 
induce PCK1 mRNA in rat hepatocytes (Massillon et al., 2003) indicating the potential 
for propionate to control its own metabolism.  Effects of glucagon on propionate and 
lactate metabolism in hepatocytes from neonatal calves indicate increased 
gluconeogenesis from propionate and lactate, but not glycerol (Donkin and Armentano, 
1994), suggesting PCK1 as a point of regulation point of gluconeogenesis by glucagon.  
However the direct effects of propionate and hormones on PCK1 mRNA in bovine 
hepatocytes have not been determined.  We hypothesized that propionate and cAMP act 
to induce PCK1 mRNA expression and insulin opposes these effects on PCK1 mRNA in 
liver hepatocytes.  
The primary objective of this research was to determine the direct effects of 
propionate, cAMP, dexamethasone and insulin on expression of PCK1 mRNA in the 
neonatal calf hepatocytes.  The secondary objective was to evaluate the effects of 





genes, including mitochondrial phosphoenolpyruvate carboxykinase (PCK2), pyruvate 
carboxylase (PC), and glucose-6-phosphotase (G6PC).  
Materials and methods 
Care and Use of Hepatocyte Donor Animals  
All experimental procedures involving animals were approved by the Purdue 
University Animal Care and Use Committee. 
Intact male dairy calves were fed colostrum at birth followed by milk diet at 10% 
of birth weight and delivered as two equal portions fed twice daily.  Animal were selected 
as hepatocyte donors within 7 d of age, were given heparin (1, 000 USP, Sagent 
Pharmaceuticals, Schaumburg, IL) intravenously and anesthetized with 1% propofol (6 
mg/kg calf body weight, Hospira Inc. Lake Forest, IL) via intravenous injection.  The 
caudate process was excised and the animals were euthanized immediately by 
intravenous injection of saturated potassium chloride (150 mg/kg calf body weight, 
Sigma, St. Louis, MO).  
Hepatocyte Monolayer Preparation and Culture 
Liver cells were dispersed via collagenase perfusion as described previously 
(Donkin and Armentano, 1993).  The isolated hepatocytes were plated onto 35-mm 









 in Dulbecco’s Modified Eagles Media 
(DMEM) containing 20% Fetal Bovine Serum (FBS) and 1% antibiotic, antimycotic 
solution (Sigma, St. Louis, MO).  After 4 h, the plating medium and unattached cells 
were removed by aspiration and media was replaced by DMEM containing 10% FBS and 
1% antibiotic, antimycotic solution. 
Twenty hours after seeding plates, media was removed by aspiration, and 
replaced with treatments in DMEM supplemented with 1% Bovine Serum Albumin 
(BSA, Merck Millipore, Billerica, MA) and 1% antibiotic, antimycotic solution.  Time-
dependent effect of propionate was determined in presence of either 0 or 2.5 mM 
propionate for 3, 6, 12, and 24 h.  Concentration-dependence of the propionate induction 
was determined in presence of 0, 0.625, 1.25, 2.5 and 5.0 mM propionate for 6 h.  The 
effects of hormonal cues and relationship with propionate were tested in presence of 1 
mM 8-Br-cAMP, 5 μM dexamethasone, 100 nM insulin, 2.5 mM propionate, or their 
designated combinations for 6 h.   
RNA extraction and real time RT-PCR 
Total RNA was isolated using Trizol reagent and 50 µg of the resulting RNA was 
further purified using RNeasy Mini Kit (Qiagen, Inc., Thousand Oaks, CA).  A total of 2 
µg of purified sample was reverse transcribed to cDNA using an Omniscript reverse 
transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random decamers (Ambion, Foster 
City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA).  Abundance of cDNA for 





QPCR Master Mix (Agilent Technologies, Inc., Santa Clara, CA) and primers described 
below.  A cDNA pool was generated from an equivalent quantity of cDNA from each 
sample.  A 1:4 dilution series of the cDNA pool was used to generate the standard curve.  
No template control (using water as template) and no reverse transcription control (using 
RNA pool as template) were included in the real-time PCR analysis.  The forward and 
reverse primers for PCK1, PCK2, PC, G6PC and 18S were: bovine PCK1, 
AGGGAAATAGCAGGCTCCAGGAAA, CACACGCATGTGCACACACACATA; 
bovine PCK2, TGACTGGGCAAGGGGAGCCG, GGGGCCACCCCAAAGAAGCC; 
bovine PC, CCACGAGT TCTCCAACACCT, TTCTCCTCCAGCTCCTCGTA; bovine 
G6PC, TGATGGACCAAGAAAGATCCAGGC, 
TATGGATTGACCTCACTGGCCCTCTT; bovine 18S, 
ACCCATTCGAACGTCTGCCCTATT, TCCTTGGATGTGGTAGCCGTTTCT.  
Reactions were as follows: 1 cycle at 95 °C for 3 min; 40 cycles at 95 °C for 10 s, 60 °C 
for 20 s; 1 cycle at 95 °C for 1 min, 55 °C for 30 s, and 95 °C for 30 s.  Samples were 
analyzed in triplicate and PCR reaction efficiencies were between 90% and 110%.  Mean 
values for transcripts evaluated were normalized to mRNA abundance of 18S within each 
sample.  Data are expressed as arbitrary units of mRNA relative to 18S abundance within 
sample. 
Statistical Analysis 
All experiments were conducted in at least three separate cell preparations using 





procedure of SAS 9.2 (SAS Inst. Inc., Cary, NC), and any heteroscedastic data were 
adjusted to achieve normality using a natural logarithm transformation.  Analyses of 
variance of the data were performed using the Proc Mixed procedure of SAS.  For 
analyzing data associated with time, the model accounted for the fixed effects of cell 
preparation, time, treatment, and their interactions.  Insignificant interactions were 
excluded from the model.  Preplanned comparisons between treatments within the same 
time point were made using pdiff option.  For all other data, the model accounted for the 
fixed effects of cell preparation and treatment.  Dunnett’s test was used for conducting 
the pre-planned comparisons between each hormonal treatment and the no-addition 
control.  Data are reported as least square means and standard errors.  Means were 
considered different when P ≤ 0.05, and tendency for difference was declared when 0.05 
< P ≤ 0.10. 
Results 
The time course of the induction of PCK1 mRNA indicated a treatment by time 
interaction (P = 0.05) (Figure 3.1).  The expression of PCK1 mRNA was induced (P ＜ 
0.05) to 188% and 163% of control with the addition of 2.5 mM propionate to the media 
for 3 and 6 h respectively.  There was a lack of response (P > 0.10) when propionate was 
included for 12 and 24 h.  In contrast, 2.5 mM propionate consistently induced (P ＜ 
0.05) PCK2 mRNA to approximately 350% of control at 3, 6, 12 and 24 h, and also 





24h.  The expression of G6PC mRNA was not affected (P > 0.10) by propionate at any 
time point.  
The effect of propionate concentration on expression of PCK1, PCK2, PC and 
G6PC mRNA in bovine hepatocytes was investigated by exposing to 0, 0.625, 1.25, 2.5 
and 5.0 mM propionate for 6 h (Figure 3.2).  Expression of PCK1 mRNA was increased 
(P ＜ 0.05) by 2.5 mM propionate, and not altered by lower and higher concentrations 
tested.  Expression of PCK2 mRNA showed a similar pattern with PCK1 mRNA.  A 
linear induction was observed for PC mRNA in response to different concentrations of 
propionate.  The expression of G6PC mRNA was not affected (P > 0.10) by any of the 
concentrations tested.   
Expression of PCK1 mRNA also tended to increase (0.05 ＜ P ＜ 0.10) in 
response to 1.0 mM cAMP as well as the combination of 1.0 mM cAMP and 5.0 µM 
dexamethasone, but not altered (P > 0.10) by 5.0 µM dexamethasone alone (Figure 3.3).  
In presence of 100 nM insulin, the induction of PCK1 mRNA by propionate, or cAMP, or 
the combination of cAMP and dexamethasone was repressed to the basal level.   
Discussion 
Cytosolic phosphoenolpyruvate carboxykinase catalyzes formation of 
phosphoenolpyruvate (PEP) from oxaloacetate (OAA), a critical reaction for 
gluconeogenesis in liver and kidney.  The induction of PCK1 mRNA by cAMP in 





and Iynedjian, 1982, Christ et al., 1988) and rat hepatoma cells (Sasaki et al., 1984, 
Granner et al., 1986) showing direct induction of PCK1 in both models.  Likewise the 
lack of induction of PCK1 mRNA by dexamethasone is in agreement with the 
observations showing dexamethasone as a permissive factor for induction of PCK1 
mRNA by glucagon rather than a stimulation hormone itself in rat hepatocytes (Salavert 
and Iynedjian, 1982, Christ et al., 1988).  The dominant inhibitory effect of insulin on 
cAMP-induced PCK1 mRNA is again consistent with studies in rat (Granner et al., 
1983).  Generally, the responses to these hormonal cues were similar between rat and 
bovine calf hepatocytes.  
Increased PCK1 activity and mRNA expression is observed as feed intake 
recovers during the transition period through early lactation in dairy cows (Greenfield et 
al., 2000), a condition linked to increased ruminal propionate production.  We attempted 
to determine the direct role of propionate in the regulation of PCK1 mRNA expression in 
bovine liver through utilization of in vitro hepatocytes culture system under controlled 
hormonal conditions.  The induction of PCK1 mRNA by propionate in bovine 
hepatocytes is in agreement with the previous observation in rat hepatocytes (Massillon et 
al., 2003).  The counteractive effect of insulin in propionate-induced PCK1 mRNA 
expression corroborates our previous observations that induction of PCK1 mRNA by 
propionate is tempered by the inhibitory effect of concurrently elevated blood insulin 
concentrations during postruminal propionate infusion in lactating dairy cows (Zhang et 
al., 2013).  Data reported here, to the best of our knowledge, describes for the first time 
the direct antagonistic relationship between propionate and insulin in regulating PCK1 





PCK1 mRNA and gluconeogenic activity have not yet been determined for bovine or 
other species and require further investigation. 
In contrast to PCK1, expression of PCK2 mRNA is generally considered 
constitutive, and lack of acute hormonal and nutritional regulation (Beale et al., 2007).  
However, propionate induces PCK2 mRNA expression in a concentration-dependent 
manner in bovine hepatocytes.  The significant role of PCK2 in gluconeogenesis, lipid 
metabolism and TCA cycle activity has been recently emphasized by overexpression of 
PCK2 in PCK1 knockout mice and hepatocytes (Méndez-Lucas et al., 2013), and 
silencing PCK2 in gluconeogenic tissues in rats and hepatocytes (Stark et al., 2014).  In 
contrast to rat and mouse liver, in which PCK2 only accounts for about 5% and 1% of the 
total phosphoenolpyruvate carboxykinase activity (Nordlie and Lardy, 1963, Wiese et al., 
1991), ruminants present approximately equal activities of PCK1 and PCK2 (Agca et al., 
2002).  Approximately 60% of propionate flux to glucose depends on the enzyme PCK2 
in goat hepatocytes (Aiello and Armentano, 1987).   Our data has brought new insights 
regarding the nutritional regulation of PCK2 expression.  However, limited available 
supporting data makes it difficult to predict whether the changes in PCK2 mRNA would 
result in changes of in the enzyme expression and activity, and relevant physiological 
consequences. 
Pyruvate carboxylase catalyzes pyruvate to form OAA, an important intermediate 
for both gluconeogenesis and fatty acids oxidation (Jitrapakdee et al., 2008).  The 
expression of PC mRNA is increased during feed restriction (Velez and Donkin, 2005) 
and at parturition in dairy cows (Greenfield et al., 2000), to support increased 





et al., 2010).  Our data demonstrate that increased supply of propionate, the major 
gluconeogenic substrate in ruminants, can also induce PC mRNA expression, even 
though gluconeogenesis from propionate does not directly rely on PC.  Our results are in 
accordance with previous report which shows linear induction of PC mRNA expression 
by propionate in bovine neonatal hepatocytes within the concentration range from 0 to 
11.5 mM (Xu and Wang, 2006).  An increase in PC mRNA expression directly reflects an 
increased enzyme activity in dairy cattle (Greenfield et al., 2000).  Because OAA pool 
size is determined by the PCK and PC, a matched increase in both enzymes may be 
important for maintaining the OAA pool and preventing the depletion of OAA and 
potential reduction of TCA activity.  Reduction of OAA pool has been considered as a 
major cause for ketosis in dairy cows (Baird et al., 1968).  Bovine PC expresses six 5’ 
untranslated region variants that are transcribed from three different promoters (Hazelton 
et al., 2008).  The regulation of PC expression by fatty acids through activating its 
promoter 1, indicating nutritional control of bovine PC gene transcription (White et al., 
2011).  Nevertheless, the molecular mechanisms by which propionate induces PC mRNA 
expression remain to be elucidated.   
Glucose-6-phosphatase catalyzes the metabolism of glucose from glucose-6-
phosphate (G6P) to glucose, the last step of gluconeogenesis and glycogenolysis.  The 
mRNA expression of G6PC is not regulated by propionate in the present study, despite of 
the increases in other key gluconeogenic genes.  Propionate has been shown to stimulate 
glycogen synthesis in hepatocytes isolated from fed sheep at concentration- dependent 
manner, and the induction is mediated through increased intracellular concentration of 





stimulation of G6PC mRNA could result in increased glycogen storage rather than 
increased glucose output.  However this is not likely the case as previous studies indicate 
increased extracellular glucose production with glucagon addition to bovine hepatocytes 
(Donkin and Armentano, 1994).  Furthermore available data indicate that G6PC activity 
is largely unopposed by glucose kinase in bovine (Raggi et al., 1963).  Consequently as 
long as the basal activity of G6PC is adequate and increase in flux to G6P should result in 
increased glucose release.  Additional measures are needed to confirm the relationship 
between G6PC mRNA and G6PC activity and effects of propionate on glucose 
production and release from bovine hepatocytes.  
Conclusions 
Overall, these data indicate a role of propionate to regulate its own metabolism 
through controlling the mRNA expression for PCK1, PCK2 and PC.  The inductive effect 
of propionate on PCK1 mRNA expression is mimicked by cAMP.  Furthermore, the 
effects of either propionate or cAMP to induce PCK1 mRNA expression are eliminated 
by the addition of insulin suggesting that gluconeogenesis in bovine is controlled by a 
combination of direct responses to substrates and hormones acting to control key genes 
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Figure 3. 1. Effect of time of exposure to propionate on expression of key genes for 
gluconeogenesis in bovine hepatocytes. Data are presented for cytosolic 
phosphoenolpyruvate carboxykinase (PCK1, panel A) mRNA, mitochondrial 
phosphoenolpyruvate carboxykinase (PCK2, panel B) mRNA, pyruvate carboxylase (PC, 
panel C) mRNA, and glucose-6-phosphotase (G6PC, panel D) mRNA in bovine calf 
hepatocytes.  Twenty hours after seeding plates, hepatocytes were exposed to 0 mM 
propionate (dotted line, open circle) or 2.5 mM propionate (dotted line, solid square) for 
the indicated time period and then harvested for mRNA analysis.  Data are expressed as 
arbitrary units of mRNA adjusted for 18S abundance.  Values are least square means ± 
SEM, n = 3.  Asterisk indicates means within the same time point differ (P ＜ 0.05).  
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Figure 3. 2. Effects of propionate concentrations on mRNA expression for key genes for 
gluconeogenesis in bovine hepatocyte.  Data are shown for expression of cytosolic 
phosphoenolpyruvate carboxykinase (PCK1) mRNA, mitochondrial 
phosphoenolpyruvate carboxykinase (PCK2) mRNA, pyruvate carboxylase (PC) mRNA, 
and glucose-6-phosphotase (G6PC) mRNA in bovine calf hepatocytes.  Twenty hours 
after seeding plates, hepatocytes were exposed to 0, 0.625, 1.25, 2.5 or 5 mM propionate 
for 6 h and then harvested for mRNA analysis.  Data are expressed as arbitrary units of 
mRNA adjusted for 18S abundance.  Values are least square means ± SEM, n = 3.  
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Figure 3. 3. Effects of propionate, insulin, cAMP, dexamethasone, and their designated 
combinations on expression of cytosolic phosphoenolpyruvate carboxykinase (PCK1) 
mRNA in bovine calf hepatocytes. Twenty hours after seeding plates, hepatocytes were 
exposed to the designated treatment for 6 h and then harvested for mRNA analysis.  Data 
are expressed as fold induction of PCK1 mRNA for each treatment relative to the no-
addition control.  Values are least square means ± SEM, n = 3.  Means with * differ (P ＜ 
0.05) from the no-addition control, and means with # tend to differ (0.05 < P ＜ 0.10) 








CHAPTER 4. PROPIONATE INDUCES BOVINE CYTOSOLIC 
PHOSPHOENOLPYRUVATE CARBOXYKINASE TRANSCRIPTION: ROLE 
OF HEPATIC NUCLEAR FACTOR 4α 
Abstract 
Expression of cytosolic phosphoenolpyruvate carboxykinase (PCK1) is a pace-
setting step for gluconeogenesis and is controlled in liver by several transcription factors 
including hepatic nuclear factor 4α (HNF-4α).  The primary objective of the present study 
was to determine whether propionate regulates bovine PCK1 transcription through a 
mechanism involving HNF4α.  The second objective was to determine the action of 
cyclic AMP (cAMP), glucocorticoids and insulin, hormonal cues known to modulate 
glucose metabolism, on bovine PCK1 transcriptional activity.  The proximal promoter 
from -1238 to +221 bp relative to the transcription start site (TSS) of the bovine PCK1 
gene was ligated to a Firefly luciferase reporter and transfected into H4IIE hepatoma 
cells.  Cells were exposed to treatments for 23 h and luciferase activity was determined in 
cell lysates.  Activity of PCK1 promoter was induced by propionate in a concentration 
dependent manner (0, 0.25, 0.5, 1.0, and 2.5 mM), and maximally induced 8-fold with 2.5 





significantly muted by addition of 100 nM insulin.  Additionally, activity of PCK1 
promoter was induced 19-fold by 2.5 mM butyrate, but was not altered by 2.5 mM 
acetate or 2.5 mM glycerol.  Activity of PCK1 promoter was induced 2-fold by either 1.0 
mM 8-bromo-cyclic AMP or 5.0 µM dexamethasone, and 3.2-fold by their combination.  
Induction by cAMP and dexamethasone was repressed 50% by 100 nM insulin.  
Propionate, cAMP, and dexamethasone acted synergistically to induce the PCK1 
promoter activity by approximately 24-fold.  Propionate-responsive regions, identified by 
5’ deletion analysis were located between -1238 and -409 bp and between -85 and +221 
bp relative to the TSS of the bovine PCK1 gene.  Deletions of the core sequences of the 
two putative HNF4α sites (+68 through +72 bp and −1078 through −1074 bp relative to 
the TSS) decreased the responsiveness of bovine PCK1 promoter to propionate and 
butyrate by approximately 40%.  Taken together, these data indicate that propionate 
regulates its own metabolism through transcriptional stimulation of the bovine PCK1 
gene.  This induction is mediated, at least partially, by the two putative HNF4α binding 
sites in the bovine PCK1 promoter.  








The cytosolic phosphoenolpyruvate carboxykinase (PCK1) is a pace-setting 
enzyme of gluconeogenesis in the liver and kidney and catalyzes the irreversible 
formation of phosphoenolpyruvate from oxaloacetate (Rognstad, 1979).  It is well 
documented in non-ruminant species that hepatic expression of PCK1 is actively 
regulated by hormones and nutrients at the transcriptional level, most notably through 
induction by glucagon and glucocorticoids, effects that are repressed by insulin action 
(Hanson and Reshef, 1997).  Accordingly, expression of PCK1 is induced by starvation 
and reduced during feeding (Hanson and Reshef, 1997).  However, in ruminants, the 
expression of PCK1 is not altered during feed restriction (Velez and Donkin, 2005), but is 
induced in response to increased feed intake (Greenfield et al., 2000) and monensin 
feeding (Karcher et al., 2007), conditions that are linked to increased ruminal propionate 
production.  Likewise hepatic PCK1 mRNA is increased when propionate is 
intravenously infused in neonatal calves (Donkin et al., 2009).  Expression of PCK1 is 
maintained with postruminal propionate infusions in lactating dairy cows despite elevated 
insulin concentrations (Zhang et al., 2013), a hormone that potently and rapidly represses 
PCK1 mRNA expression (Granner et al., 1983, Chakravarty and Hanson, 2007).   
Hepatic nuclear factor 4α is a member of the nuclear receptor superfamily and 
abundantly expressed in the liver and is required for liver-specific gene expression in 
response to hormones and nutrients (Sladek et al., 1990, Babeu and Boudreau, 2014).  A 
number of metabolic pathways in liver, including gluconeogenesis, are regulated by 





positively regulated by HNF4α (Gonzalez, 2008).  Upon binding to its recognition sites in 
a gene promoter, HNF4α is able to recruit co-activators of transcription factors such as 
peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) to stimulate 
transcriptional activity (Gonzalez, 2008).  The critical role of HNF4α in activating PCK1 
and G6PC, and therefore gluconeogenesis, has also been confirmed using hepatocytes 
from mice lacking hepatic HNF4α (Rhee et al., 2003).  Studies using primary rat 
hepatocytes and H4IIE hepatoma cells indicate that short-chain fatty acids (SCFA), 
including propionate and butyrate, modulate expression of PCK1 mRNA and G6PC 
mRNA, and transcriptional induction of the mouse G6PC gene requires HNF4α 
(Massillon et al., 2003). 
These observations led us to ask if the induction of PCK1 mRNA expression by 
propionate in liver of dairy cattle might be due to direct activation of the bovine PCK1 
promoter through a mechanism involving HNF4α.  We were likewise interested in 
determining the relationship between propionate, glucagon, glucocorticoids and insulin 
on bovine PCK1 transcription.  Here we show that propionate has an inductive effect on 
the transcriptional activity of the bovine PCK1 promoter, which is dominant to the 
repressive effect of insulin, and synergistic to the inductive effect of the combination of 
cAMP and dexamethasone.  We also demonstrate that two putative HNF4α-binding sites 
within the bovine PCK1 promoter are responsible, at least in part, for propionate-induced 





Materials and methods  
Promoter-Luciferase Reporter Constructs 
Bovine PCK1 proximal promoter sequence was obtained from National Center for 
Biotechnology Information database.  The DNA sequence containing the proximal 
promoter region from −1238 through +221 bp relative to the TSS of bovine PCK1 (Gene 
ID: 282855) was linked to a Firefly luciferase reporter.  The promoter region corresponds 
to bases 59151952 through 59150494 of the bovine chromosome 13.  To determine the 
propionate-responsive elements within the bovine PCK1 promoter, 5’ nested deletions of 
the proximal promoter region were individually linked to the Firefly luciferase reporter.  
The target promoter sequences were amplified from bovine liver genomic DNA by PCR 
using the primers presented in Table 1.  The amplified PCR products were purified using 
agarose gel electrophoresis and the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA) 
and each was ligated into the pDrive cloning vector (Qiagen, Valencia, CA), which was 
used to transform QIAGEN EZ Competent Cells (Qiagen, Valencia, CA).  Positive 
clones were grown individually overnight for plasmid DNA isolation using the Wizard 
Plus SV Miniprep kit (Promega, Madison, WI).  The cloned sequences were then excised 
from pDrive and ligated separately into the pGL3-Basic vector (Promega, Madison, WI).  
Each PCK1promoter-luciferase plasmid was used to transform competent JM109 
Escherichia coli, and positive clones were grown individually overnight for plasmid 
DNA isolation using the Wizard Plus SV Miniprep kit (Promega, Madison, WI).  Insert 





DNA Sequencing Low Throughput Laboratory of Purdue Genomics Core Facility 
(Purdue University, West Lafayette, IN) using the ABI 3700 sequencer (Amersham 
Biosciences, Piscataway, NJ). 
In Silico Promoter Sequence Analysis 
Bovine PCK1 proximal promoter sequence (-1238/+221) was analyzed using the 
TRANSFAC transcription factor analysis tool (BIOBASE, Beverly, MA). The search 
parameters were limited to liver specific factors, high-quality matrices, and set to 
minimize false positives. 
Site-Directed Mutagenesis  
The essentiality of putative HNF4α binding sites within the bovine PCK1 gene 
located at +68 through +72 bp and −1078 through −1074 bp relative to TSS were tested 
using site-directed mutagenesis.  Mutations of the putative HNF4α binding sites were 
generated using the GENEART Site-Directed Mutagenesis System kit (Life 
Technologies, Grand Island, NY) following the manufacturer protocols.  The primers 
used for the mutagenesis are shown in Table 1.  Three mutant promoters were tested 
relative to the wild type promoter (PCK1 (WT)) in these experiments.  The mutant HNF4α 
(+68_+72)
 –
 was created by deleting the core sequence of the putative HNF4α binding site at 
+68 through +72 bp (5’-CTCTG-3’) using the PCK1 (WT) as template.  The mutant 
HNF4α (−1078 _−1074)
 –





site at −1078 through −1074 bp (5’-CAAAG-3’) using the PCK1 (WT) as template.  The 
double mutant HNF4α (+68_+72)
–/ HNF4α (−1078_−1074)
 – 
was created by deleting the core 
sequences of the putative HNF4α site at +68 through +72 bp (5’-CTCTG-3’) and site at 
−1078 through −1074 bp (5’-CAAAG-3’) using the mutant HNF4α (−1078_−1074)
 –
 as 
template.  All promoter-luciferase reporter plasmids were sequenced at the DNA 
Sequencing Low Throughput Laboratory of Purdue Genomics Core Facility to verify the 
target mutations.   
Cell Culture  
Rat hepatoma H4IIE cells were obtained from the American Type Culture 
Collection (Manassas, VA) and grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Sigma-Aldrich, St. Louis, MO) containing 4.5 mM glucose supplemented with 
10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO) and antibiotics (10mg/L 
piperacillin and 10mg/L ciprofloxacin; Sigma-Aldrich, St. Louis, MO) at 37 °C, 95% 
relative humidity, and 5% CO2.  Cells were seeded in 24-well Costar tissue culture plates 
at a target density of 75,000 cells per cm
2
 and grown for 24 hours to achieve 
approximately 80% confluence.  
Test of Promoter Function  
Transient transfections in H4IIE cells were performed using Lipofectamine 2000 





transfection, cell culture media was DMEM supplemented with 1% bovine serum 
albumin (BSA, Merck Millipore, Billerica, MA) but without antibiotics.  A volume of 
100 µL of the Lipofectamine-plasmid mixture containing 98 µL of Opti-MEM I Reduced 
Serum Medium (Life Technologies Inc., Grand Island, NY), 2 µL of lipofectamine, 0.8 
µg of each tested plasmid and 0.008 µg of a Renilla pRL-CMV luciferase plasmid 
(Promega, Madison, WI) was added to each well.  Cotransfection of Renilla pRL-CMV 
luciferase plasmid was used to normalize transfection efficiency.   
Five hours after transfection, media was removed by aspiration, and replaced with 
the treatment additions to DMEM containing 1% BSA and antibiotics (10mg/L 
piperacillin and 10mg/L ciprofloxacin).  Cells were exposed to treatments for 23 h.  Basal 
promoter activity and responsiveness to propionate and hormones were tested in a series 
of complementary experiments.  Briefly, DMEM supplemented with 1% BSA and 
antibiotics (10mg/L piperacillin and 10mg/L ciprofloxacin) was used to determine the 
basal promoter activity.  Responsiveness of PCK1 promoter was determined in the 
presence of 0, 0.25, 0.5, 1.0, or 2.5 mM propionate.  The effects of SCFA and glycerol on 
the PCK1 promoter were tested in DMEM containing 1% BSA and antibiotics and either 
2.5 mM acetate, 2.5 mM propionate, 2.5 mM butyrate, or 2.5 mM glycerol.  Media 
without SCFA or glycerol served as the control.  The relationship between propionate and 
hormone additions was determined in the presence of either 2.5 mM propionate, 100 nM 
insulin, 1.0 mM 8-Br-cAMP, 5.0 μM dexamethasone or their combinations.  To 
determine the location of DNA regulatory elements required for propionate action, 5’ 
nested deletions of PCK1 proximal promoter ligated to luciferase reporter were 





The role of HNF4α in PCK1 promoter response to propionate and butyrate was 




, and the 
double mutant HNF4α (+68_+72)
–/ HNF4α (−1078_−1074)
–
.  Each mutant plasmid was 
individually transfected into H4IIE cells, and cells were exposed to either no addition or 
2.5 mM of propionate or 2.5 mM butyrate.   
Luciferase Activity  
Following 23 h exposure to treatments, media was removed by aspiration and 
cells were washed with 250 µL ice-cold 1× PBS and harvested in 80 µL 1× passive lysis 
buffer (Promega, Madison, WI).  Firefly luciferase and Renilla luciferase were quantified 
with the Dual-Luciferase Reporter Assay system and the Stop & Glo Reagent kit 
according to the manufacturer’s instruction (Promega, Madison, WI).  Fluorescence was 
determined with Magellan 5.0 software (Tecan, Research Triangle Park, NC) using a 
Tecan GENios Pro spectrofluorometer.  Promoter activity was expressed as the ratio of 
Firefly luciferase to Renilla luciferase, and treatment effect was expressed as the fold 
change relative to the no-addition controls.  
Statistical Analysis 
All experiments were conducted in at least three separate cell preparations using 
three replicates per treatment.  Data were analyzed for normality using the Univariate 





adjusted to achieve normality using a natural logarithm transformation.  Analyses of 
variance were performed using the Proc Mixed procedure of SAS 9.2.  Data from the full 
length PCK1 promoter (-1238/+221) were evaluated using a model that accounted for the 
fixed effects of treatment and cell preparation.  Data from multiple promoter luciferase 
reporter constructs were evaluated using a model that accounted for the fixed effects of 
construct and cell preparation.  For the data that were not adjusted using logarithm 
transformation, least squares means and standard errors were reported.  For the data that 
were adjusted using logarithm transformation, least squares means and 95% confidence 
interval were reported using the original scale.  Tukey-Kramer studentized adjustments 
were used to separate treatment means when main effects were significant.  Means were 
considered different when P < 0.05.   
Results 
Basal promoter activity of the bovine PCK1 gene.   
The pGL3- luciferase family of constructs served as controls in this experiment.  
The promoterless parent vector, pGL3-Basic, served as a negative control, and pGL3- 
SV40 Promoter containing a SV40 promoter element served as a positive control.  The 
pGL3- SV40 Promoter was able to drive luciferase expression by 6.5-fold (P < 0.05; 
Figure 4.1).  The ability of the bovine PCK1 promoter (-1238/+221) to drive luciferase 
expression was greater (P < 0.05) than the pGL3-Basic negative control, and similar to 





increased (P < 0.05) the basal PCK1 promoter activity (Figure 4.1).  The minimum PCK1 
promoter construct (-85/+221) was still able to drive luciferase expression compared with 
the pGL3-Basic negative control (P < 0.05; Figure 4.1).  
Dose-dependent induction of bovine PCK1 transcription by propionate.   
Propionate at 0.25, 0.5, 1.0, and 2.5 mM linearly increased (P < 0.05) the activity 
of bovine PCK1 promoter (-1238/+221) (Figure 4.2).  Compared with 0 mM propionate, 
0.25 mM propionate induced (P < 0.05) PCK1 promoter activity by 1.5 fold, and 2.5 mM 
propionate increased (P < 0.05) the promoter activity by approximately 8-fold (Figure 
4.2).  
Responsiveness of bovine PCK1 transcription to SCFA and glycerol.   
The activity of bovine PCK1 promoter (-1238/+221) was induced (P ＜ 0.05) by 
2.5 mM propionate and 2.5 mM butyrate, but not by 2.5 mM acetate (P > 0.05; Figure 
4.3).  The induction by butyrate was greater (P ＜ 0.05) than propionate (Figure 4.3).  
Glycerol, another gluconeogenic substrate, did not affect (P > 0.05) PCK1 promoter 
activity, indicating that a lack of general effect of gluconeogenic precursors on PCK1 





Responsiveness of bovine PCK1 transcription to propionate and hormonal cues.   
Dexamethasone and cAMP, when present alone, induced (P < 0.05) the bovine 
PCK1 promoter (-1238/+221) by approximately 2-fold compared with the no-addition 
control (Figure 4.4).  The combination of cAMP and dexamethasone increased (P < 0.05) 
the PCK1 promoter activity by 3.2-fold, which was repressed 50% by insulin (Figure 
4.4).  Propionate alone induced (P < 0.05) the promoter activity by approximately 8-fold 
(Figure 4.4).  When propionate was combined with cAMP or dexamethasone, the 
inductive effects were magnified (P < 0.05) to 12-fold and 10-fold respectively, and the 
combination of propionate, cAMP and DEX synergistically increased (P < 0.05) the 
promoter activity by about 24-fold, which was greater (P < 0.05) than the induction by 
propionate alone (Figure 4.4).  In presence of propionate, insulin was without effect (P > 
0.05) on bovine PCK1 promoter activity (Figure 4.4).  
Propionate-responsive regions within the promoter of the bovine PCK1 gene.   
Compared with the PCK1 promoter (-1238/+221), deletion from -1238 to -409 bp 
resulted in increased basal promoter activity, but caused a significant loss of propionate 
inducibility (P < 0.05; Figure 4.5).  Further deletion from -409 to -85 bp did not alter the 
responsiveness to propionate (Figure 4.5).  The minimum promoter construct (-85/+221) 
was sufficient to mediate responsiveness to propionate compared with the negative 





and from -85 to +221 bp relative to TSS accounted for the robust induction of bovine 
PCK1 promoter by propionate.  
Role of the HNF4α binding sites in propionate-induced bovine PCK1 transcription.   
In silico analysis of the bovine PCK1 promoter sequence using TRANSFAC 
revealed two putative HNF4α binding site at +68 to +72 bp and −1078 to − 1074 bp 
relative to TSS respectively (Figure 4.6).  The role of HNF4α binding sites in mediating 
propionate and butyrate regulation of bovine PCK1 transcription was examined by 
deleting the core sequences of HNF4α binding site at +68 to +72 bp (mutant HNF4α 
(+68_+72)
–
), at −1078 to −1074 bp (mutant HNF4α (−1078_−1074)
–




).  Compared with the PCK1 (WT), the mutant 
HNF4α (+68_+72)
–
, mutant HNF4α (−1078_−1074)





 had increased basal promoter activity, but responsiveness to 
propionate or butyrate was depressed by about 40% (P < 0.05; Figure 4.7).  The basal 
activity and responsiveness to propionate or butyrate were not different among the three 
mutants.  These results indicate the putative HNF4α binding sites are responsible, at least 
in part, for propionate- and butyrate-mediated induction of bovine PCK1 transcription. 
Discussion 
Feeding strategies that increase ruminal propionate production are often utilized 





early lactation in dairy cows (David Baird, 1982, Duffield et al., 1998, Aschenbach et al., 
2010).  The gluconeogenic effect of propionate appears to be mediated by elevated 
expression of PCK1 mRNA (Donkin et al., 2009; Zhang et al., 2013).  Induction of PCK1 
mRNA expression in primary rat hepatocytes and H4IIE cells in response to propionate is 
due to transcriptional activation (Massillon et al., 2003).  Available data indicate that 
transcription of PCK1 in liver requires an important transcription factor HNF4α 
(Puigserver, 2005, Gonzalez, 2008).  In this study, we demonstrate that propionate, a 
major gluconeogenic precursor in ruminants, directly regulates bovine PCK1 
transcription and the putative HNF4α binding sites within the PCK1 promoter are 
responsible for, at least in part, responsiveness of PCK1 to propionate.   
The increase in transcription of bovine PCK1 in response to propionate and 
butyrate appears to be a specific effect of these SCFA as acetate was without effect.  
Likewise, the effects on PCK1 do not appear to be mediated by the availability of 
gluconeogenic precursors as glycerol was also without effect.  Short-chain fatty acids 
have been recently identified as ligands for G-protein-coupled receptors GPR41 and 
GPR43, also known as free fatty acid receptor (FFAR) 3 and FFAR2 respectively (Brown 
et al., 2003, Layden et al., 2013). These two receptor types show ubiquitous expression 
throughout the human body (Tang et al., 2012) and bovine tissues (Wang et al., 2009, 
Yonezawa et al., 2009).  Acetate and butyrate preferentially bind to FFAR2 and FFAR3 
respectively, whereas propionate binds to both receptors.  The receptor preferences may 
have provided some possible explanations for the different responsiveness of bovine 
PCK1 transcription to SCFA.  However, the differential effects of SCFA to stimulate 





acetate to increase histone acetylation and recruiting HNF4α  to G6PC promoter 
(Massillon et al., 2003).  Additionally, butyrate has been reported to activate the 
cAMP/protein kinase A (PKA) pathway independent on the G-protein-coupled receptors 
in Caco-2 cells (Wang et al., 2012), and the cAMP/PKA pathway is able to increase 
transcription of HNF4α in hepatoma HepG2 cells (Dankel et al., 2010).  Likewise, 
propionate and butyrate have been used to enhance HNF4α expression in HeLa cells 
(Guan et al., 2011).  Taken together, the underlying signaling pathway mediated by 
propionate and butyrate at the molecular level to stimulate PCK1 transcription remains 
unclear, but the present data and other supporting evidences demonstrate involvement of 
HNF4α.  
Expression of HNF4α is most abundant in liver, and expressed to a lesser extent 
in kidney and intestine (Zhong et al., 1994, Jiang et al., 1995).  This transcription factor 
plays an important role in regulation of PCK1 and G6PC gene expression by both 
hormonal and nutritional cues (Gonzalez, 2008).  Upon activation by hormonal and 
nutritional cues, HNF4α recruits its co-activators and accessory proteins to promoter 
elements which in turn induce the expression of target genes via binding to its recognition 
sites as a homodimer (Puigserver, 2005).  Binding sites of HNF4α have been identified 
within the promoter of the rat PCK1 and G6PC (Hanson and Reshef, 1997, Massillon et 
al., 2003, Chakravarty et al., 2005).  The induction of mouse G6PC transcription by 
propionate and butyrate requires binding of HNF4α to the G6PC promoter (Massillon et 
al., 2003).  It is noteworthy that deletions of the two binding sites for HNF4α did not 





indicating requirements of other cis-elements to mediate the full responsiveness to these 
SCFA.   
Although PCK1 is critical as a rate-limiting enzyme for gluconeogenesis, it also 
plays an important cataplerotic role in oxaloacetate (OAA) metabolism.  Sufficient OAA 
in the cell is necessary to enable to capacity for the complete oxidation of acetyl-CoA 
that is generated from fatty acids through β-oxidation during negative energy balance in 
dairy cattle (Baird et al., 1968, Li et al., 2012).  Increased PCK1 activity that is 
unmatched by change in PC activity may lead to diminution of OAA (Jitrapakdee et al., 
2008).  Propionate can replenish the OAA pool through propionyl CoA and 
methylmalonyl-CoA metabolism (Aschenbach et al., 2010).  In contrast, butyrate cannot 
be converted to OAA.  The present data indicate butyrate is a potent inducer of bovine 
PCK1 transcription and exhibits roughly double the effect of a similar concentration of 
propionate.  Because butyrate carbon does not enter the OAA pool, the potential exists to 
reduce the oxidative capacity of the TCA by increased PCK1 activity that is not matched 
by metabolism that replenishes OAA.  Induction of PCK1 by butyrate without a matched 
increase in propionate supply may lead to a pattern of metabolism marked by a reduction 
of OAA pool, and therefore compromised capacity for acetyl-CoA oxidation.  Therefore, 
the ratio between propionate and butyrate supply to the liver may be critical for 
determining PCK1 expression and the impact on size of OAA pool.  A resulting buildup 
of the intracellular acetyl CoA may potentiate hepatic ketogenesis in an attempt to shuttle 
energy to peripheral tissues.  Increased butyrate to propionate ratio in the rumen by 
dietary supplementation of α-amylase is reported to be accompanied with elevated blood 





(DeFrain et al., 2005, Tricarico et al., 2005, Tricarico et al., 2008).  Increased ketogenesis 
in response to increased ruminal supply of butyrate (Huhtanen et al., 1993) supports a 
role of butyrate in altering hepatic energy metabolism.  Our data have suggested an 
underlying molecular mechanism for these observations.  The regulation of bovine PCK1 
transcription and impact of propionate and butyrate proportions in conjunction with 
impacts on cellular capacity for gluconeogenesis and fatty acid oxidation was not 
investigated in the present study and warrants further investigation.  
In addition to regulation by propionate and butyrate, bovine PCK1 promoter 
activity was also regulated by cAMP, dexamethasone and insulin.  The pattern of 
regulation by these hormones in bovine is similar to rat in that PCK1 is stimulated by 
glucagon (via cAMP) and glucocorticoids and repressed by insulin (Hanson and Patel, 
1994, Hanson and Reshef, 1997). These similarities are not surprising because the 
promoter (-1000 bp to the TSS) of the rat and bovine PCK1 gene have a number of high 
conserved regions that corresponds to several transcription factor binding sites such as 
the cAMP response element (CRE) (Yang et al., 2009).  In rat PCK1 promoter, a CRE is 
located at -85 bp and is involved in the full induction of rat PCK1 promoter by both 
cAMP (Roesler, 2000) and glucocorticoids (Imai et al., 1990, Scott et al., 1998, Cassuto 
et al., 2005).  The CRE binds cAMP response element binding protein and 
CCAAT/enhancer binding proteins to mediate the induction by cAMP and 
dexamethasone, which can be totally abolished by insulin (Chakravarty et al., 2005).  A 
putative CRE was also identified within the bovine PCK1 promoter located at -94 bp 
(Figure 4.6), and may be the key regulatory elements mediating the responsiveness of 





It is noteworthy that despite highly conserved sites for some transcription factors, 
the occurrence and position of binding sites for several transcription factors such as sterol 
regulatory element-binding protein 1 (SREBP1) within PCK1 gene are variable among 
species (Yang et al., 2009).  For example, two binding sites for SREBP1 have been 
identified in rat PCK1 gene promoter located at approximately -322 and -590 bp 
respectively (Chakravarty et al., 2005).  In contrast, only one putative SREBP1 binding 
site was identified within the bovine PCK1 promoter located at -430 bp (Figure 4.6).  The 
repressive effect of insulin on rat PCK1 transcription is mediated by SREBP1 along with 
HNF4α, PGC-1α, and the forkhead box O transcription factor (Chakravarty et al., 2004, 
Chakravarty et al., 2005).  The variability of occurrence and position of binding sites for 
SREBP1 between cow and rat is of interest regarding the fact that ruminants has been 
long known to be more resistant to the effect of insulin compared with nonruminants 
(Jarrett and Potter, 1953, Bergman et al., 1989).   
Even though the regulation of PCK1 transcription by cAMP, dexamethasone, 
insulin, and propionate has been reported in rodents (Hanson and Reshef, 1997, 
Massillon et al., 2003), to our knowledge, this is the first study to investigate the 
relationship between propionate and these hormonal cues in regulation of PCK1 
transcription in any species.  The extent of induction of bovine PCK1 transcription in 
response to propionate far exceeded the induction by cAMP and dexamethasone, and this 
effect is not repressed by insulin, indicating propionate is a primary regulator for bovine 
PCK1 expression.  The dominant induction of PCK1 transcription by propionate over the 
repressive effect of insulin is consistent with the unique characteristic of ruminants that 





blood (Aschenbach et al., 2010).  Additionally, stimulation of PCK1 transcription by 
hormonal signals like cAMP and dexamethasone is likely to be more important during 
feed restriction.  Otherwise, a decrease in expression of PCK1 mRNA would be an 
anticipated outcome of reduced propionate supply, but clearly this is not the case in vivo 
as PCK1 mRNA in liver is not altered during feed restriction over a 5-d period in dairy 
cows (Velez and Donkin, 2005).  Although the present data and other supporting work 
from our laboratory indicate propionate as a regulator of PCK1 expression, there is 
additional research needed to identify the timing, duration of response, and impact on the 
physiology of cattle and other ruminants.  
Conclusions 
 These data demonstrate hormonal and nutritional regulation of PCK1 
transcription in bovine.  The promoter activity of bovine PCK1 is induced by cAMP, 
dexamethasone, propionate and butyrate.  Insulin exhibits a dominant inhibition on the 
cAMP- and dexamethasone- induced PCK1 transcription, but fails to repress propionate-
induced PCK1 transcription.  The propionate- or butyrate- induced PCK1 transcription 
requires the presence of HNF4α binding elements within the promoter.  Propionate, as a 
major gluconeogenic precursor in ruminants, controls its own metabolism in liver via 
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Table 4. 1. Primer sequences used to amplify the promoter regions of the bovine PCK1 gene and for the site-directed 
mutagenesis. 
Promoter construct Primer sequence (5’- 3’) 
PCK1 promoter (-1238/+221)  Forward: GGTCTCATTGCTCAAGTGTAATCG 
PCK1 promoter (-815/+221) Forward: AATCCACAAGGCAGGTGTGACTGA 
PCK1 promoter (-409/+221) Forward: ACCACTGCTCTATTCTGGCAACCA 
PCK1 promoter (-251/+221) Forward: CAGAAGTTGTGTAAAGGCCTGCCA 
PCK1 promoter (-85/+221) Forward: AGTCGAGCCTCTCTGGGTGTG 
All promoter regions of PCK1 Reverse: AGAGTTGAGGGTGTCCATGGTTGT 
Mutant HNF4α (+68_+72)
–
 Forward: AAGGGACCCTTTGGCTGACCTGATCGTCCA 
 Reverse: TGGACGATCAGGTCAGCCAAAGGGTCCCTT 
Mutant HNF4α (−1078_−1074)
–
 Forward: AGGTTCCAGGAAGGGGTCCCTTACAAGAGG 
 Reverse: CCTCTTGTAAGGGACCCCTTCCTGGAACCT 















Figure 4. 1. Basal promoter activity of the bovine PCK1 gene.  The PCK1 promoter (-1238/+221) and 5’ deletions were 
individually ligated to Firefly luciferase reporter and transfected into the rat hepatoma H4IIE cells. Cotransfection of Renilla 
pRL-CMV luciferase plasmid was used to normalize transfection efficiency.  Five hours after transfection, cells were 
incubated in DMEM containing 1% BSA and antibiotics (10mg/L piperacillin and 10mg/L ciprofloxacin) for 23 h and 
luciferase activities were then determined in cell lysates. The pGL3-Basic was promoterless and used as a negative control, and 
the pGL3-SV40 Promoter served as positive control.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla 
luciferase.  Values are least squares means and 95% confidence intervals, n = 3.  Means with different superscripts differ (P ＜ 









Figure 4. 2. Propionate induction of the bovine PCK1 promoter.  The PCK1 promoter (-1238/+221) was ligated to Firefly 
luciferase reporter and transfected into rat hepatoma H4IIE cells. Cotransfection of Renilla pRL-CMV luciferase plasmid was 
used to normalize transfection efficiency.  Five hours after transfection, cells were exposed to 0, 0.25, 0.5, 1.0 or 2.5 mM of 
propionate for 23 h and luciferase activities were then determined in cell lysates.  Promoter activity is expressed as ratio of 
Firefly luciferase to Renilla luciferase.  Treatment effects are expressed as the fold change relative to the no-addition control.  
Values are least squares means and 95% confidence intervals, n = 3.  Means with different superscripts differ (P ＜ 0.05).  
Induction of PCK1 promoter activity shows a linear regression with increasing propionate concentrations.  
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Figure 4. 3. Effects of short-chain fatty acids and glycerol on the activity of the bovine PCK1 promoter.  The PCK1 promoter 
(-1238/+221) was ligated to Firefly luciferase reporter and transfected into rat hepatoma H4IIE cells. Cotransfection of Renilla 
pRL-CMV luciferase plasmid was used to normalize transfection efficiency.  Five hours after transfection, cells were exposed 
to 0 or 2.5 mM acetate, 2.5 mM propionate, 2.5 mM butyrate or 2.5 mM glycerol for 23 h and luciferase activities were then 
determined in cell lysates.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla luciferase.  Treatment effects 
are expressed as the fold change relative to the no-addition control.  Values are least squares means and 95% confidence 




















































Propionate, 2.5 mM  -  -  -  -  -  -  +  +  +  +  +  +  +  +  
cAMP, 1.0 mM  -  +  -  -  +  +  -  +  -  +  -  +  -  +  
Dexamethasone, 5.0 µM  -  -  +  -  +  +  -  -  +  +  -  -  +  +  































































Figure 4. 4. Effects of short-chain fatty acids and glycerol on the activity of the bovine PCK1 promoter.  The PCK1 promoter 
(-1238/+221) was ligated to Firefly luciferase reporter and transfected into rat hepatoma H4IIE cells. Cotransfection of Renilla 
pRL-CMV luciferase plasmid was used to normalize transfection efficiency.  Five hours after transfection, cells were exposed 
to 2.5 mM propionate, 100 nM insulin, 1.0 mM cAMP, 5.0 μM dexamethasone or the combinations indicated for 23 h and 
luciferase activities were then determined in cell lysates.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla 
luciferase. Treatment effects are expressed as the fold change relative to the no-addition control.  Values are least squares 





















Figure 4. 5. Identification of propionate-responsive regions within the bovine PCK1 promoter.  The PCK1 promoter (-
1238/+221) and its nested 5’ deletions were individually ligated to Firefly luciferase reporter and transfected separately into 
the rat H4IIE cells. Cotransfection of Renilla pRL-CMV luciferase plasmid was used to normalize transfection efficiency.  
Five hours after transfection, cells were exposed to either 0 or 2.5 mM of propionate for 23 h and luciferase activities were 
then determined in cell lysates.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla luciferase.  Propionate 
induction for each promoter reporter is expressed as fold change relative to the no-addition control.  Values are least squares 







Figure 4. 6. A diagram of the proximal promoter (-1238 through +221) of the bovine 
PCK1 gene and its 5’ truncation deletion promoter regions. Transcription start site is 
indicated as TSS.  Putative transcription factor binding sites within the full-length 
promoter (-1238 through +221) was identified using the TRANSFAC transcription factor 
analysis tool (BIOBASE, Beverly, MA).  The searching parameters were limited to liver 
specific factors, high-quality matrices, and were set to minimize the number of false 
positives.  Abbreviations for common transcription factors: C/EBP = CCAAT/Enhancer 
Binding Protein, NF-1A = Nuclear Factor 1A, STAT = Signal Transducer and Activator 
of Transcription, HNF4α = Hepatic Nuclear Factor 4 alpha, SREBP = Sterol Regulatory 
Element-Binding Protein, Sp1 = Specificity Protein 1, USF = Upstream Stimulatory 
Factor, HNF-1β = Hepatic Nuclear Factor 1 beta, CREB = cAMP Response Element 







Figure 4. 7. The role of the putative HNF4α binding sites within the bovine PCK1 
promoter in mediating the responsiveness to propionate or butyrate. The PCK1 (WT) and 
the mutant HNF4α (+68_+72)
–, mutant HNF4α (−1078_−1074)
–




 were individually ligated to Firefly luciferase reporter and 
transfected into rat hepatoma H4IIE cells.  Cotransfection of Renilla pRL-CMV 
luciferase plasmid was used to normalize transfection efficiency.  Five hours after 
transfection, cells were exposed to either 0 or 2.5 mM of propionate or 2.5 mM butyrate 
for 23 h and luciferase activities were then determined in the cell lysates.  Promoter 
activity is expressed as ratio of Firefly luciferase to Renilla luciferase.  Inductions by 
propionate or butyrate for each promoter reporter are expressed as fold change relative to 
the no-addition control.  Values are least squares means ± SEM, n = 3.  Means with 






CHAPTER 5. PROPIONATE AND CYCLIC AMP INDUCED BOVINE PCK1 
GENE TRANSCRIPTION IS CONCURRENTLY MEDIATED BY CRE AND 
HNF4α BINDING ELEMENTS 
Abstract 
Cytosolic phosphoenolpyruvate carboxykinase (PCK1), a key glucogenic enzyme 
in liver and kidney, is controlled at the transcriptional level. Our objective was to 
determine regulatory elements within the bovine PCK1 promoter that control 
transcription in response to cyclic AMP (cAMP), glucocorticoids, propionate and 
butyrate.  Transcription factor binding sequences were identified within the bovine PCK1 
proximal promoter for cAMP response element (CRE) at -94 through -87 and for Hepatic 
Nuclear Factor 4α (HNF4α) at +68 through +72 and -1078 through -1074 respectively. 
To test control of transcription, the wild-type bovine PCK1 promoter from -1238 through 
+221 bp (PCK1 (WT)) was ligated to a luciferase reporter gene. The essentiality of CRE 
and the two putative HNF4α binding elements was determined using site-directed 
deletions of the core transcription factor binding regions within the PCK1 promoter 
DNA. Seven mutants were tested: a single mutant lacking CRE, a single mutant lacking 





bp, a double mutant lacking both HNF4α sites, a double mutant lacking CRE at -94 
through -87 bp and HNF4α at +68 through +72 bp, a double mutant lacking CRE at -94 
through -87 bp and HNF4α at −1078 through −1074 bp, and a triple mutant lacking the 
three sites.  H4IIE cells were transfected with the promoter-reporter constructs and 
exposed to 2.5 mM propionate, 2.5 mM butyrate, 1 mM cAMP, 5 μM dexamethasone or 
their designated combinations for 23 h. Exposure to cAMP, dexamethasone, cAMP+ 
dexamethasone, propionate, cAMP+ propionate, cAMP+ dexamethasone + propionate, 
and butyrate induced expression of the PCK1 (WT) relative to the no addition controls by 
2.0, 2.3, 3.9, 7.6, 9.2, 18.0 and 15.4± 0.9 X respectively.  A similar pattern was observed 
for each single mutant and the double mutant lacking CRE at -94 through -87 bp and 
HNF4α at −1078 through −1074 bp.  Responses to all treatments were completely 
abolished for the double mutant lacking CRE at -94 through -87 bp and HNF4α at +68 
through +72 bp. These data indicate that cAMP, dexamethasone, propionate, and butyrate 
share common cis-acting elements to induce bovine PCK1 transcription.  The CRE at -94 
through -87 bp and HNF4α binding element at +68 through +72 bp act synergistically to 
mediate the full responsiveness of the bovine PCK1 promoter to cAMP, dexamethasone, 
propionate and butyrate as well as the synergistic effect of cAMP, dexamethasone and 
propionate.  







The cytosolic phosphoenolpyruvate carboxykinase (PCK1) gene encodes the key 
enzyme for hepatic gluconeogenesis that catalyzes the formation of phosphoenolpyruvate 
from oxaloacetate.  The expression of PCK1 is acutely induced at transcriptional level by 
glucagon acting through cyclic AMP (cAMP) and glucocorticoids (Hanson and Reshef, 
1997, Chakravarty et al., 2005).  The stimulation of rat PCK1 gene transcription by 
cAMP and glucocorticoids is mediated through multiple DNA regulatory elements (Short 
et al., 1986, Quinn et al., 1988). A cAMP response element (CRE) located at about -85 bp 
upstream of the transcription start site (TSS) of rat PCK1 promoter is an essential 
elements in mediating the basal promoter activity of rat PCK1 and its responsiveness to 
cAMP (Short et al., 1986, Bokar et al., 1988), glucocorticoids  (Imai et al., 1990) and 
their synergistic action (Chakravarty et al., 2005).   
A previous study in our laboratory indicated that the transcription of bovine PCK1 
is not only stimulated by cAMP, dexamethasone, but also by propionate and butyrate, 
two major short- chain fatty acids (SCFA) produced from ruminal fermentation, and 
propionate act synergistically with cAMP and dexamethasone to stimulate the promoter 
(Zhang et al., 2014).  Hepatic Nuclear Factor 4 alpha (HNF4α) is an important liver-
specific transcription factor, and mediates the activation of key gluconeogenic genes, 
including PCK1 and glucose-6-phosphatase (G6PC) in response to hormonal or 
nutritional signals (Gonzalez, 2008).  The binding of HNF4α to its recognition site within 
the promoter of rat PCK1 is required to mediate the maximum response to 





butyrate also requires binding of HNF4α to the G6PC promoter (Massillon et al., 2003).  
Functional interaction between CRE and HNF4α binding element has been observed in 
the induction of hepatic carnitine palmitoyltransferase I (CPT I) gene transcription by 
cAMP (Louet et al., 2002).   
We hypothesized that cAMP, dexamethasone, propionate, and butyrate activate 
common cis-regulatory elements within the bovine PCK1 promoter to stimulate its 
transcription.  The objectives were to 1) identify the location of the candidate cis-
elements within the bovine PCK1 promoter, specifically CRE and HNF4α; 2) determine 
the essentiality of the concensus CRE and putative HNF4α as well as how they interact 
with each other in mediating PCK1 transcription in response to cAMP, dexamethasone, 
propionate, and butyrate.  Here we show that the basal activity and full induction of 
bovine PCK1 promoter by cAMP, dexamethasone, propionate, butyrate and their select 
combinations all require an functional interaction of an intact concensus CRE at -94 
through -87 bp and putative HNF4α binding site at +68 through +72 bp relative to the 
TSS as double deletions of these two elements completely abolished the basal promoter 
activity of bovine PCK1 and its responsiveness to the above hormones and nutrients.  
Materials and methods  
Promoter-Luciferase Reporter Constructs 
Bovine PCK1 proximal promoter sequence was obtained from National Center for 





promoter region from −1238 through +221 bp relative to the TSS of bovine PCK1 (Gene 
ID: 282855) was linked to a Firefly luciferase reporter.  The promoter region corresponds 
to bases 59151952 through 59150494 of the bovine chromosome 13.  The target promoter 
sequence was amplified from bovine liver genomic DNA by PCR using the forward 
primer 5’-GGTCTCATTGCTCAAGTGTAATCG3’, and reverse primer 5’-
ACAACCATGGACACCCTCAACTCT3’.  The PCR product was purified using agarose 
gel electrophoresis and the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA) and 
ligated into the pDrive cloning vector (Qiagen, Valencia, CA), and used to transform 
QIAGEN EZ Competent Cells (Qiagen, Valencia, CA).  Positive clones were grown 
individually overnight and plasmid DNA was isolated using the Wizard Plus SV 
Miniprep kit (Promega, Madison, WI).  The cloned sequence was excised from pDrive 
and ligated into the pGL3-Basic vector (Promega, Madison, WI).  The PCK1 promoter-
luciferase plasmid was used to transform competent JM109 Escherichia coli, and positive 
clones were grown individually overnight for plasmid DNA isolation using the Wizard 
Plus SV Miniprep kit (Promega, Madison, WI).  Insert sequence data and directional 
orientation of the promoter region was verified by sequencing at the DNA Sequencing 
Low Throughput Laboratory of Purdue Genomics Core Facility (Purdue University, West 
Lafayette, IN) using the ABI 3700 sequencer (Amersham Biosciences, Piscataway, NJ). 
In Silico Promoter Sequence Analysis 
Bovine PCK1 proximal promoter sequence (-1238/+221) was analyzed using the 





parameters were limited to liver specific factors, high-quality matrices, and set to 
minimize false positives. 
Site-Directed Mutagenesis  
The essentiality of the concensus CRE located at -94 through -87 bp and two 
putative HNF4α binding sites located at +68 through +72 bp and −1078 through −1074 
bp respectively relative to TSS of the bovine PCK1 gene was tested using site-directed 
mutagenesis.  Deletion mutations of the core sequences for concensus CRE and putative 
HNF4α binding sites within the bovine PCK1 promoter were generated using the 
GENEART Site-Directed Mutagenesis System kit (Life Technologies, Grand Island, NY) 
following the manufacturer protocols.  Seven mutant promoters were tested relative to the 
wild- type promoter (PCK1 (WT)) in these experiments: 1) a single mutant HNF4α (+68_+72)
–
 
lacking the HNF4α site at +68 through +72 bp (5’-CTCTG-3’); 2) a single mutant 
HNF4α (−1078_−1074)
 –
 lacking HNF4α site at −1078 through −1074 bp (5’-CAAAG-3’);  3) 
a single mutant CRE (−94_−87)
–
  lacking the CRE at -94 through -87 bp (5’-TGACGTCA-




 lacking both HNF4α sites; 
5) a double mutant CRE (−94_−87)
–
 / HNF4α (+68_+72)
–
 lacking both CRE at -94 through -87 
bp and HNF4α site at +68 through +72 bp; 6) a double mutant CRE (−94_−87)
–
 / HNF4α 
(−1078_−1074)
–
 lacking CRE at -94 through -87 bp and HNF4α site at −1078 through −1074 
bp, 7) a triple mutant CRE (−94_−87)
–
 / HNF4α (+68_+72)
–/ HNF4α (−1078_−1074)
–
 lacking all 





Accordingly to manufacturer protocols, two complementary mutagenic 
oligonucleotide primers with centrally located mutation sites were used to generate a 
deletion mutation site using promoter-luciferase reporter plasmids as template.  
Specifically, mutant HNF4α (+68_+72)
 –
 was generated with forward primer 5’-
AAGGGACCCTTTGGCTGACCTGATCGTCCA-3’, and reverse primer 5’-
TGGACGATCAGGTCAGCCAAAGGGTCCCTT-3’ using the PCK1 (WT) as template.  
Mutant HNF4α (−1078/−1074)
 –
 was generated with the forward primer 5’-
AGGTTCCAGGAAGGGGTCCCTTACAAGAGG3’, and reverse primer 5’-
CCTCTTGTAAGGGACCCCTTCCTGGAACCT-3’ using the PCK1 (WT) as template.  
Double mutant HNF4α (+68_+72)
–/ HNF4α (−1078_−1074)
 –
 was generated with forward primer 
5’-AAGGGACCCTTTGGCTGACCTGATCGTCCA-3’, and reverse primer 5’-
TGGACGATCAGGTCAGCCAAAGGGTCCCTT-3’ using mutant HNF4α (−1078_−1074)
 –
 
as template.  Mutant CRE
-
, double mutant CRE (−94_−87)
–
 / HNF4α (+68_+72)
–
, double mutant 
CRE (−94_−87)
–
 / HNF4α (−1078_−1074)
 –
, and triple mutant CRE (−94_−87)
–





 were generated with the same forward primer 5’-
CCAAAGACCAGCCCCGAGTCGAGCCTCTCT-3’, and reverse primer 
5’AGAGAGGCTCGACTCGGGGCTGGTCTTTGG3’ using the PCK1 (WT), mutant 
HNF4α (+68_+72)
–
 , mutant HNF4α (−1078_−1074)
 –





 as template respectively.  All promoter-luciferase reporter plasmids 
were sequenced at the DNA Sequencing Low Throughput Laboratory of Purdue 





Cell Culture  
Rat hepatoma H4IIE cells were obtained from the American Type Culture 
Collection (Manassas, VA) and grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Sigma-Aldrich, St. Louis, MO) containing 4.5 mM glucose supplemented with 
10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO) and antibiotics (10mg/L 
piperacillin and 10mg/L ciprofloxacin; Sigma-Aldrich, St. Louis, MO) at 37 °C, 95% 
relative humidity, and 5% CO2.  Cells were seeded in 24-well Costar tissue culture plates 
at a target density of 75,000 cells per cm
2
 and grown for 24 hours to achieve 
approximately 80% confluence.  
Test of Promoter Function  
Transient transfections in H4IIE cells were performed using Lipofectamine 2000 
(Invitrogen Inc., Waltham, MA) according to the manufacturer’s instructions.  For 
transfection, cell culture media was DMEM containing 1% bovine serum albumin (BSA, 
Merck Millipore, Billerica, MA) but without antibiotics.  A volume of 100 µL of the 
Lipofectamine-plasmid mixture containing 98 µL of Opti-MEM I Reduced Serum 
Medium (Life Technologies Inc., Grand Island, NY), 2 µL of lipofectamine, 0.8 µg of 
each tested plasmid and 0.008 µg of a Renilla pRL-CMV luciferase plasmid (Promega, 
Madison, WI) was added to each well.  Cotransfection of Renilla pRL-CMV luciferase 
plasmid was used to normalize transfection efficiency.   
Five hours after transfection, media was removed by aspiration, and replaced with 





10mg/L ciprofloxacin).  Cells were exposed to treatments for 23 h.  DMEM containing 
1% BSA and antibiotics (10mg/L piperacillin and 10mg/L ciprofloxacin) was used to 
determine the basal promoter activity.  Responsiveness of the PCK1 (WT) and seven 
mutants was determined in the presence of 1.0 mM 8-Br-cAMP, 5.0 μM dexamethasone, 
2.5 mM propionate, 2.5 mM butyrate or their combinations.   
Luciferase Activity  
Following 23 h exposure to treatments, media was removed by aspiration and 
cells were washed with 250 µL ice-cold 1× PBS and harvested in 80 µL 1× passive lysis 
buffer (Promega, Madison, WI).  Firefly luciferase and Renilla luciferase were quantified 
with the Dual-Luciferase Reporter Assay system and the Stop & Glo Reagent kit 
according to the manufacturer’s instruction (Promega, Madison, WI).  Fluorescence was 
determined with Magellan 5.0 software (Tecan, Research Triangle Park, NC) using a 
Tecan GENios Pro spectrofluorometer.  Promoter activity was expressed as the ratio of 
Firefly luciferase to Renilla luciferase, and treatment effect was expressed as the fold 
change relative to the no-addition controls.  
Statistical Analysis 
All experiments were conducted in three separate cell preparations using three 
replicates per treatment.  Data were analyzed for normality using the Univariate 





performed using the Proc Mixed procedure of SAS 9.2.  The basal promoter activity was 
analyzed using a model accounted for the fixed effects of cell preparation and promoter 
construct.  To test the responsiveness of each promoter construct to different treatments, 
the model accounted for the fixed effects of cell preparation and treatment.  To compare 
the responsiveness of each mutant promoter with the PCK1 (WT) within treatments, the 
model accounted for the fixed effects of cell preparation and promoter construct.  Data 
are reported as least squares means and standard errors.  Tukey-Kramer studentized 
adjustments were used for the post-hoc multiple comparisons.  Means were considered 
different when P < 0.05. 
Results 
Identification of regulatory elements within the bovine PCK1 proximal promoter.  
In silico analysis of the bovine PCK1 promoter sequence using TRANSFAC 
revealed three clusters of regulatory elements within the bovine PCK1 proximal promoter 
from -1238 through +221 bp relative to the TSS (Figure 5.1).  The first cluster was 
located at -430 through +80 bp within which a concensus sites for CRE at -94 through -
87 bp and a putative HNF4α binding site at +68 through +72 bp were identified.  In 
addition, binding sites for Sterol Regulatory Element-Binding Protein (SREBP) 1, 
SREBP2, Specificity Protein 1 (Sp1), Upstream Stimulatory Factor (USF), Hepatic 
Nuclear Factor 1 beta (HNF-1β), and Signal Transducer and Activator of Transcription 





CCAAT/Enhancer Binding Protein (C/EBP) binding site located at approximately -820 
bp.  The third cluster was located at -1238 through -1060 bp and contained a putative 
HNF4α binding site at −1078 to −1074 bp, a C/EBP site at approximately -1234 bp as 
well as binding sites for Nuclear Factor 1A (NF-1A), C-Jun and STAT (Figure 5.1).   
Role of CRE and HNF4α binding elements in basal promoter activity of bovine 
PCK1.   
The basal activity of the PCK1 (WT) was greater (P ＜ 0.05) than the promoterless 
negative control (pGL3-Basic), and was not different from the positive control (pGL3- 
SV40 Promoter) (Figure 5.2).  Compared with the PCK1 (WT), the basal promoter activity 
of the single mutant CRE (−94_−87)
– , HNF4α (+68_+72)
–











  and CRE (−94_−87)
–
 / HNF4α (−1078_−1074)
–
  
were not altered.  The basal activity of the double mutant CRE (−94_−87)
 –
 / HNF4α (+68_+72)
 
–
 and the triple mutant CRE (−94_−87)
 –





significantly reduced (P ＜ 0.05) compared with the PCK1 (WT) and was not different 
from the negative control (pGL3-Basic).  These data indicate that the concensus CRE at -
94 through -87 bp and the putative HNF4α binding site at +68 through +72 bp are 





Role of CRE and HNF4α binding elements in hormonal induction of the promoter 
for bovine PCK1.   
The activity of the PCK1 (WT) was induced (P ＜ 0.05) approximately 2-fold by 
either cAMP or dexamethasone and 4-fold by their combination (Figure 5.3).   The 









double mutant CRE (−94_−87)
 –
 / HNF4α (−1078_−1074)
 –
 to cAMP, dexamethasone and 
their combination was not different (P > 0.05) from the PCK1 (WT) (Figure 5.3).  The 





dexamethasone was not different (P > 0.05) from the PCK1 (WT), but its induction by 
cAMP and the combination of cAMP and dexamethasone was reduced (P ＜ 0.05) 
compared with the PCK1 (WT) (Figure 5.3).  The double mutant CRE (−94_−87)
 –
 / HNF4α 
(+68_+72)
 –
 and triple mutant CRE (−94_−87)
 –




 were not 
responsive to cAMP, dexamethasone and their combination at all (Figure 5.3).  These 
data indicate that double deletions of the two HNF4α binding sites result in partial 
elimination (P ＜ 0.05) of the cAMP induced PCK1 promoter activation.  Double 
deletions of the CRE
 
at -94 through -87 bp and HNF4α binding site +68 through +72 bp 
completely abolished (P ＜ 0.05) the induction of the PCK1 promoter by cAMP, 





Role of CRE and HNF4α binding elements in propionate and butyrate -induced 
bovine PCK1 transcription.   
Activity of the PCK1 (WT) was induced (P ＜ 0.05) 8-fold by propionate and 16-
fold by butyrate (Figure 5.4).  In presence of propionate and cAMP, the promoter activity 
was induced (P ＜ 0.05) by over 9-fold.  When propionate was combined with cAMP and 
dexamethasone, the induction was increased (P ＜ 0.05) to 18-fold (Figure 5.4).  
Propionate, butyrate, and the combinations of propionate with cAMP and dexamethasone 
induced the single mutant CRE (−94_−87)
–







double mutant CRE (−94_−87)
–
 / HNF4α (−1078_−1074)
 –
 to a similar extent as the PCK1 (WT), 
but were without effect for the double mutant CRE (−94_−87)
–
 / HNF4α (+68_+72)
 –
 and the 
triple mutant CRE (−94_−87)
–




.  The induction of the 




 by propionate, butyrate, and the 
combinations of propionate with cAMP and dexamethasone were all decreased (P ＜ 
0.05) compared with the PCK1 (WT), but was still measurable.  These data indicate that the 
double deletions of the two HNF4α binding sites partially eliminated (P ＜ 0.05), 
whereas double deletion of CRE at -94 through -87 bp and HNF4α binding site at +68 
through +72 bp completely abolished (P ＜ 0.05) the inductions of the PCK1 by 






Expression of PCK1 is a key step for gluconeogenesis in liver and is acutely 
induced at transcriptional level by glucagon through cAMP and glucocorticoids (Hanson 
and Reshef, 1997) and by SCFA (Massillon et al., 2003).  Recent studies in our 
laboratory suggest cAMP, dexamethasone, and propionate work synergistically to induce 
bovine PCK1 transcription (Zhang et al., 2014).  The goal of the present study was to 
identify cis-regulatory elements within the bovine PCK1 promoter that mediate the 
induction of bovine PCK1 transcription by propionate, butyrate, cAMP, dexamethasone 
and determine the synergistic effects of cAMP, dexamethasone and propionate.  Our 
results demonstrate that two cis-regulatory elements, the CRE site at -94 through -87 bp 
and a putative HNF4α binding site at +68 through +72 bp, are required for the full 
stimulation of the bovine PCK1 promoter by cAMP, dexamethasone, propionate, and 
butyrate. These conclusions are based on the observations that site-specific deletion of 
the one of the two sites alone in the bovine PCK1 promoter (-1238/+221) did not alter, 
whereas deletions of these two sites together completely abolished the promoter activity 
induced by cAMP, dexamethasone, propionate, butyrate and their combinations.  
The palindromic sequence 5’- TGACGTCA-3’ of CRE  located at -85 bp relative 
to the TSS of rat PCK1 promoter was one of the first elements identified in cAMP 
responsiveness of PCK1 (Short et al., 1986, Bokar et al., 1988), and was later recognized 
to be required for glucocorticoids induction of PCK1 (Imai et al., 1993).  Similarly, a 
CRE with the consensus sequence 5’- TGACGTCA-3’ was identified within the bovine 





presence of CRE within the promoter is not sufficient to mediate PCK1 gene activation. 
The requirements of multiple cis-elements to mediate the full induction of PCK1 by 
cAMP and glucocorticoids is consistent with observations for rat PCK1, indicating that a 
primary protein binding site from -250 through -234 bp cooperates with CRE to mediate 
the  full induction of rat PCK1 transcription by cAMP (Liu et al., 1991). Indeed, it is now 
generally accepted that multiple cis-regulatory elements, namely a cAMP response unit 
(CRU) and a glucocorticoid response unit (GRU) are responsible for induction by cAMP 
(Roesler, 2000) and glucocorticoids (Chakravarty et al., 2005) respectively, and both 
CRU and GRU contain a CRE.   
The present study suggests that the concensus CRE site at -94 through -87 bp and 
the putative HNF4α binding site at +68 through +72 bp function in a context-specific 
manner to regulate bovine PCK1 transcription.  Binding of HNF4α to the distal promoter 
region with binding of C/EBPα to the CRE is necessary to mediate the response to 
glucocorticoids for the rat PCK1 promoter (Cassuto et al., 2005).  Likewise, cooperativity 
between CRE and HNF4α binding site in the hepatic CPT I gene promoter are required 
for the full stimulatory effect of cAMP on transcription of CPT I gene (Louet et al., 
2002).  Even though two putative HNF4α binding sites have been tested in the present 
study, the one located at −1078 through −1074 bp did not appear to function either alone 
or through interaction with the CRE site as deletion of this HNF4α site either alone or 
along with the CRE site had no impact on the responses of PCK1 promoter to propionate, 
butyrate, cAMP or dexamethasone.  It is noteworthy that the sequences of HNF4α 
binding site at  −1078 through −1074 bp are different from that at +68 through +72 bp, 





proximity and localization between CRE and HNF4α binding site may be critical, which 
was not tested in the present study.  The requirement of specific distance (about 3 kb) 
between the CRE and HNF4α binding sites has been observed for cAMP activation of the 
CPT I gene, and deletions of the DNA sequences between these two sites remarkably 
reduced the responsiveness to cAMP (Louet et al., 2002).  However, the distance between 
CRE and either HNF4α binding site within bovine PCK1 is much smaller than that in the 
CPT I gene (Louet et al., 2002).  Additonally, the distance between CRE and the 
nonessential HNF4α binding site (−1078 through −1074 bp) within the bovine PCK1 
promoter is similar to the distance between CRE and HNF4α binding site that are 
required for the response to glucocorticoids in the rat PCK1 gene (Cassuto et al., 2005).  
Therefore, the different essentality of the two HNF4α binding sites within the bovine 
PCK1 promoter is more likely due to sequence difference rather than their distance from 
CRE.   
Short-chain fatty acids have been identified as ligands for G-protein coupled 
receptors in multiple tissue types (Brown et al., 2003) and are recognized as signaling 
molecules that  play multiple roles in regulation of nutrient metabolism (Layden et al., 
2013). The induction of bovine PCK1 transcription by propionate and butyrate is 
consistent with the observations of induction of rat PCK1 by SCFA (Massillon et al., 
2003).  Butyrate also increases PCK1 mRNA expression in Caco-2 cells, a response that 
is accompanied by elevated intracellular cAMP level (De Vadder et al., 2014).  Likewise, 
based on data in Caco-2 cells, butyrate activates cAMP response element binding protein 
(CREB) through increasing intracellular cAMP level (Wang et al., 2012).  Binding of 





transcription in non-ruminants (Gonzalez et al., 1989, Chrivia et al., 1993).  We show 
here the first time that that propionate and butyrate activate bovine PCK1 transcription 
through the consensus sequence of CRE located at -94 through -87 bp and a putative 
HNF4α binding site located at +68 through +72 bp.  Furthermore, we demonstrate that 
the same sites are essential for the induction of bovine PCK1 transcription by cAMP.  
Taken together, these data suggest a convergence of these signaling pathways to induce 
PCK1 transcription in bovine.  
Our major focus was to identify the cis-regulatory elements within the bovine 
PCK1 promoter that are responsible for the induction by cAMP, dexamethasone, 
propionate, and butyrate.  Although we did not directly determine the transcription 
factors that bind to the concensus CRE and the putative HNF4α sites in the current study, 
the available evidence suggests that multiple transcription factors and co-activators may 
be recuited to these cis-elements and form “protein scaffolds” to regulate PCK1 
transcription.  For example, CREB and CCAAT/Enhancer Binding Protein (C/EBP) 
family proteins can bind to the CRE in the rat PCK1 promoter in response to cAMP (Park 
et al., 1993, Roesler, 2000) and dexamethasone (Imai et al., 1993, Chakravarty et al., 
2005).  The transcription factor HNF4α is a member of the nuclear receptor superfamily 
(Taraviras et al., 1994) and a positive regulator of transcription of key hepatic 
gluconeogenic genes, including PCK1 and G6PC (Gonzalez, 2008).  Binding of HNF4α 
to mouse G6PC promoter is involved in induction of G6PC transcription by propionate 
and butyrate (Massillon et al., 2003).  Upon binding to its recognition sites in the 
promoter of its target gene as a homodimer, HNF4α recruits other transcription factors 





target genes (Gonzalez, 2008).  The coactivator PGC-1α is a critical regulator of PCK1 
and G6PC expression in liver, and is a major target for acute regulation by hormonal cues 
(Yoon et al., 2001).  Furthermore, both HNF4α and PGC-1 are induced by the cAMP-
PKA-CREB signaling pathway. The potential interactions and crosstalk among CREB, 
HNF4α and PGC-1 may be important mechanisms for mediating the synergistic effect of 
propionate, cAMP and dexamethasone.   
The convergence and synergy in regulation of PCK1 transcription in response to 
propionate, cAMP and dexamethasone demonstrate potential interaction of hormonal and 
nutritional status and relevant physiological consequences in ruminant animals.  
Interventions such as glucagon or glucocorticoids injection have been used to promote 
gluconeogenesis or prevent and treat ketosis or fatty liver in early-lactation cows (Braun 
et al., 1970, Bobe et al., 2003, Nafikov et al., 2006).  Likewise, feeding strategies that 
utilize propylene glycol and monensin to increase propionate supply also show 
impressive benefits for early lactation dairy cows (Studer et al., 1993, Duffield et al., 
1998, Nielsen and Ingvartsen, 2004).  Our data suggest that the beneficial effects of these 
hormonal applications or feeding strategies can be partially attributed to the stimulation 
of PCK1 transcription and thus increased gluconeogenic capacity in liver.  Furthermore, 
when glucagon and glucocorticoids level are elevated, increased propionate supply may 






The data indicate that cAMP, dexamethasone, propionate, and butyrate shared 
common cis-elements to regulate bovine PCK1 transcription. The cis-elements, a CRE 
site at -94 through -87 bp and a putative HNF4α binding element at +68 through +72 bp 
within the bovine PCK1 promoter acted cooperatively to mediate the full induction by 
either cAMP, dexamethasone, propionate or butyrate as well as the synergistic induction 
by cAMP, dexamethasone and propionate.  Responses to these stimuli were completely 
abolished by mutations lacking the CRE at -94 through -87 bp and HNF4α binding 
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Figure 5. 1. Putative transcription factor binding sites for the proximal promoter region of bovine PCK1 (-1238 to +221). 
Transcription start site is indicated as TSS.  The promoter sequence was analyzed using the TRANSFAC transcription factor 
analysis tool (BIOBASE, Beverly, MA).  The searching parameters were limited to liver specific factors, high-quality 
matrices, and were set to minimize the number of false positives.  Abbreviations for common transcription factors: C/EBP = 
CCAAT/Enhancer Binding Protein, NF-1A = Nuclear Factor 1A, STAT = Signal Transducer and Activator of Transcription, 
HNF4α = Hepatic Nuclear Factor 4 alpha, SREBP = Sterol Regulatory Element-Binding Protein, Sp1 = Specificity Protein 1, 






















Figure 5. 2. The effect of CRE and HNF4α binding sites on basal transcriptional activity of the bovine PCK1 promoter. 
The wild-type PCK1 promoter (PCK1 (WT)) and the family of mutated promoters were individually ligated to Firefly luciferase 
reporter and transfected into H4IIE cells.  The plasmids pGL3-Basic and pGL3- SV40 Promoter were used as negative control 
and positive control respectively.  Cotransfection of Renilla pRL-CMV luciferase plasmid was used to normalize transfection 
efficiency.  Five hours after transfection, cells were exposed to DMEM containing 1% BSA and antibiotics for 23 h and 
luciferase activities were then determined in cell lysates.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla 
luciferase.  Data are reported as the least squares means ± standard error of mean from three separate experiments.  Asterisks 






















Figure 5. 3. The effect of CRE and HNF4α binding sites on hormonal induction of the bovine PCK1 promoter. The wild-type 
PCK1 promoter (PCK1 (WT)) and the family of mutated promoters were individually ligated to Firefly luciferase reporter and 
transfected into H4IIE cells.  Cotransfection of Renilla pRL-CMV luciferase plasmid was used to normalize transfection 
efficiency.  Five hours after transfection, cells were exposed to 1 mM 8-Br-cAMP (cAMP), 5 μM dexamethasone or their 
combination for 23 h and luciferase activities were then determined in cell lysates.  Promoter activity is expressed as ratio of 
Firefly luciferase to Renilla luciferase.  Effects within each promoter reporter construct are expressed as fold changes relative 
to the no-addition controls and reported as the least squares means ± standard error of mean from three separate experiments.  
Means with different letters within each promoter reporter construct differ (P ＜ 0.05). In addition, single degree of freedom 
tests are used to compare the differences between the PCK1 (WT) and each individual mutant in response to each treatment.  

















Figure 5. 4. The effect of CRE and HNF4α binding sites on induction of the bovine PCK1 promoter by propionate, butyrate 
and the combination of propionate with cAMP and dexamethasone. The wild-type PCK1 promoter (PCK1 (WT)) and the family 
of mutated promoters were individually ligated to Firefly luciferase reporter and transfected into H4IIE cells.  Cotransfection 
of Renilla pRL-CMV luciferase plasmid was used to normalize transfection efficiency.  Five hours after transfection, cells 
were exposed to 2.5 mM propionate, the combination of 2.5 mM propionate and 1 mM 8-Br-cAMP (cAMP), the combination 
of 2.5 mM propionate and 1 mM cAMP and 5 μM dexamethasone, or 2.5 mM butyrate for 23 h and luciferase activities were 
then determined in cell lysates.  Promoter activity is expressed as ratio of Firefly luciferase to Renilla luciferase.  Treatment 
effects within each promoter reporter construct are expressed as fold changes relative to the no-addition controls and reported 
as the least squares means ± standard error of mean from three separate experiments.  Means with different letters within each 
promoter reporter construct differ (P ＜ 0.05).  In addition, single degree of freedom tests are used to compare the differences 
between the PCK1 (WT) and each individual mutant in response to each treatment.  Asterisk indicates a significant difference (P 
＜ 0.05) compared to the PCK1 (WT) in response to the same treatment.  
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CHAPTER 6. CONCLUSIONS 
Cytosolic phosphoenolpyruvate carboxykinase catalyzes the conversion of OAA 
to PEP, an important cataplerotic reaction that determines TCA cycle oxidative capacity 
and rate of gluconeogenesis in liver and kidney.  Increased catabolism of OAA by PCK1 
is required during several physiological states such as feeding when there are large 
influxes of propionate into the TCA cycle in ruminants, which is critical for not only 
feeding carbon to gluconeogenesis, but also maintaining the size of OAA pool.  
Accordingly, increased PCK1 mRNA expression is associated with increased feed intake 
and monensin feeding, conditions linked to increased ruminal propionate production.  
However, the direct role of propionate in PCK1 expression and gluconeogenesis in 
bovine liver remains unclear.  The central hypothesis of this dissertation is that 
propionate regulates its own metabolism in liver of dairy cattle through regulation of the 
PCK1 gene.  The objectives of this dissertation were to determine: 1) the effect of 
elevated propionate supply on expression of key genes for gluconeogenesis, particularly 
PCK1, in liver of dairy cattle; 2) the effect of propionate on expression of PCK1 mRNA 
under controlled hormonal status in cultured primary bovine hepatocytes; 3) the effect of 
propionate on the transcriptional activity of the bovine PCK1 promoter; 4) the molecular 
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mechanism and cis-elements within the bovine PCK1 promoter responsible for the 
induction of PCK1 expression by propionate. 
 Infusion studies using mid-lactation dairy cows and neonatal calves allowed 
characterization of the changes in hepatic expression of key gluconeogenic genes in 
response to the increased propionate supply in vivo.  Expression of PCK1 and G6PC 
mRNA was induced by short-term intravenous infusion of propionate in neonatal calves, 
and was at lease maintained in mid-lactation cows receiving postruminal propionate 
infusion despite significantly elevated blood insulin concentrations.  Compared with 
cows receiving isoenergetic glucose infusion, cows receiving propionate infusion had 
greater expression of PCK1 and G6PC mRNA as well as increased gluconeogenic flux in 
liver given similar blood insulin levels between the two groups of cows.   
In order to separate the effect of propionate from the effect insulin, in vitro 
neonatal bovine hepatocytes culture were used to evaluate the direct effect of propionate 
and its relationship with the hormonal cues including insulin, cAMP and dexamethasone 
in regulating PCK1 mRNA expression.  This study confirmed that propionate induced 
PCK1 mRNA in a concentration- and time- dependent manner.  The induction of PCK1 
mRNA by propionate was mimicked by cAMP, but not by dexamethasone.  Propionate- 
and cAMP- induced PCK1 mRNA expression was eliminated by insulin.  Additionally, 
propionate also stimulated expression of PCK2 and PC in neonatal bovine hepatocytes.  
Simultaneous increase in PC expression may be important for preventing the potential 
diminution of OAA pool and reduced oxidative capacity of the TCA cycle due to 
increased PCK1 activity.   
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To elucidate whether increased PCK1 mRNA expression by propionate and 
hormonal cues was through direct regulation of PCK1 transcription, the proximal 
promoter of the bovine PCK1 gene was ligated to a luciferase reporter and transiently 
transfected into H4IIE cells. The promoter activity was determined in response to 
propionate, acetate and butyrate, cAMP, dexamethasone and insulin.  These data 
demonstrated a direct role of propionate, butyrate, cAMP, dexamethasone, but not acetate 
to induce PCK1 promoter activity.  The induction by propionate was dose-dependent, and 
was synergistically magnified in the presence of cAMP and dexamethasone.  Insulin 
completely repressed the induction of PCK1 transcription by cAMP and dexamethasone, 
but only showed a minor inhibitive effect on the propionate-induced PCK1 transcription.  
Butyrate induced PCK1 transcription to a greater extent at the same concentration as 
propionate.  The increase in bovine PCK1 transcription in response to propionate and 
butyrate appears to be a specific effect of these SCFA as acetate was without effect.   
To reveal the underlying molecular mechanism for regulation of the bovine PCK1 
transcription by propionate, butyrate, cAMP and dexamethasone, the essentiality of the 
putative transcription factor binding sequences within the bovine PCK1 proximal 
promoter for cAMP response element (CRE) at -94 through -87 and for Hepatic Nuclear 
Factor 4α (HNF4α) at +68 through +72 and -1078 through -1074 respectively were tested 
using site-directed deletions of these elements.  These data suggested that propionate, 
butyrate, cAMP and dexamethasone shared common cis-elements to activate the bovine 
PCK1 promoter.  A CRE site at -94 through -87 bp and a putative HNF4α binding 
element at +68 through +72 bp within the bovine PCK1 promoter acted cooperatively to 
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mediate the full induction by either propionate, butyrate, cAMP or dexamethasone as 
well as the synergistic induction by propionate, cAMP, and dexamethasone.   
Taken together, these data indicate that propionate is able to control its own 
metabolism towards gluconeogenesis through stimulating PCK1 gene expression in liver 
of dairy cattle.  The induction by propionate is mediated by activation of the bovine 
PCK1 promoter through a mechanism involving two key cis-elements including a CRE 
site and a putative HNF4α binding site, which is converged with the signaling mediated 
by butyrate, cAMP or dexamethasone.  The convergence of propionate or butyrate 
signaling with cAMP and involvement of CRE suggests that propionate or butyrate may 
mediate bovine PCK1 gene expression through the cAMP-PKA-CREB pathway.  
Transcription factors CREB and HNF4α may be recruited to bind to the CRE site and the 
HNF4α binding element respectively within the bovine PCK1 promoter along with co-
activators, such as PPARγ coactivator-1, to form “protein scaffolds” in order to regulate 
PCK1 transcription.  However, whether propionate or butyrate acts as ligands for G-
protein coupled receptors or through other mechanisms to stimulate intracellular 
signaling that in turn induces PCK1 gene expression is not known and needs future 
research.  
With this new information on expression of PCK1 in response to propionate, 
butyrate, cAMP, glucocorticoids, and insulin, the regulation of gluconeogenesis can be 
better understood in cattle during different physiological states.  In presence of 
propionate, a primary regulator for PCK1 expression, gluconeogenesis is not repressed by 
the elevated blood insulin levels, which may be the underlying mechanism for the well 
known phenomenon that hepatic gluconeogenesis in ruminants are more resistant to 
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insulin compared with that in nonruminants.  During physiological states with restricted 
feed intake and thus limited propionate supply in dairy cows, maintaining PCK1 
expression by elevated concentrations of hormones such as glucagon (via cAMP) and 
glucocorticoids may be important for efficient utilization of gluconeogenic precursors 
like lactate.  During physiological states that have increased requirement for glucose, 
such as early lactation, increased PCK1 expression in response to elevated propionate 
supply enhances hepatic capacity for gluconeogenesis.  Feeding strategies to reduce the 
incidence of ketosis of early-lactation dairy cows,  such as increasing feed intake, 
supplementation of monensin and application of propylene glycol, is not only through 
increased supply of propionate, but also through enhanced hepatic gluconeogenic 
capacity.   
In addition to the critical role as a rate-limiting enzyme for gluconeogenesis, 
PCK1 also plays an important cataplerotic role in OAA metabolism, which determines 
the oxidative capacity of the TCA cycle.  During physiological states that evoke 
increased mobilization of adipose tissue and thus elevated circulating FFA 
concentrations, such as early lactation, conversion of propionate to OAA through the 
TCA cycle is important to maintain the size of OAA pool, which ensures the TCA cycle 
oxidative capacity for complete oxidation of acetyl-CoA generated from FFA β-oxidation 
and prevents FFA metabolism through  alternative pathways such as ketogenesis and re-
esterification into triglycerides and storage as liver lipids.  In contrast to propionate, 
butyrate carbon does not enter the OAA pool.  Therefore, induction of PCK1 by butyrate 
without a matched increase in propionate supply may lead to a pattern of metabolism 
marked by a reduction of the OAA pool, and therefore compromised capacity for acetyl-
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CoA oxidation, leading to metabolic disease such as ketosis and fatty liver.  Accordingly, 
an optimal ratio between ruminal propionate and butyrate production may exist to 
stimulate PCK1 activity without negatively impact the size of OAA pool.  Therefore, the 
hepatic capacity for both gluconeogenesis and complete oxidation of FFA mobilized 
from the adipose tissue can be optimized.   
The present research brings insights for the possibilities to impact hepatic 
capacity for glucose production and fatty acid oxidation through dietary manipulation in 
dairy cattle.  Our work also provides fundamental information to develop guidelines for 
optimizing health, production and reducing metabolic disorders in dairy cows.  Future 
research is needed to determine the timing and duration of response of PCK1 expression 
and activity to various propionate to butyrate ratio and the impacts on metabolism, 













   
 
Figure 6. 1. A schematic diagram of gluconeogenesis and fatty acid metabolism in liver 
of dairy cows and the impacts of increased ruminal propionate or butyrate supply on 
hepatic metabolism. Cytosolic phosphoenolpyruvate carboxykinase (PCK1) is a critical 
cataplerotic enzyme that determines the rate of gluconeogenesis and complete oxidation 
of fatty acids.  Expression and activity of PCK1 is increased by propionate or butyrate.  
Several physiological states, such as early lactation, evoke dramatic increase in glucose 
requirement and mobilization of adipose tissue and thus elevated circulating FFA 
concentrations.  Hepatic glucose production is increased with elevated propionate supply 
through stimulation of PCK1 activity (Panel A).  In addition, because propionate is 
converted to oxaloacetate (OAA), the size of the OAA pool that determines the oxidative 
capacity of the tricarboxylic acid (TCA) cycle can be maintained to completely oxidize 
acetyl-CoA generated from free fatty acids (FFA) β-oxidation.  In contrast, when PCK1 
activity is stimulated by increased supply of butyrate without a matched increase in 
propionate supply, hepatic glucose production from propionate may not be increased 
(Panel B). In addition, because butyrate is not converted to OAA, the size of the OAA 
pool that determines the oxidative capacity of the TCA cycle to complete oxidation of 
acetyl-CoA may be decreased. Consequently, acetyl-CoA is incompletely oxidized into 
ketones and FFA is re-esterified into triglycerides and stored as liver lipids, which may 
lead to ketosis and fatty liver. Bold lines indicate metabolic pathways or regulations that 
are increased, and the dotted lines indicate metabolic pathways that are decreased. 
Abbreviations: PEP, phosphoenolpyruvate; PCK2, mitochondrial phosphoenolpyruvate 
carboxykinase; PC, pyruvate carboxylase.
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